<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | A Novel Germline Compound Heterozygous Mutation of BRCA2 Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/D5YKKJGW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CCeQzihV.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CYv-CzHi.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":4.371461,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpSAwwEEloAFx9SSkYMVgoHEkkZTAJXVlZXSwdWUFBIBVZWBwIAHQNACg4=","queueTime":0,"ttGuid":"c964dded21507a6f"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029",browserID:"594460232"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/full">
<meta property="description" name="description" content="Objectives To investigate the genetic variants that are responsible for peripheral neuroblastic tumors (PNTs) oncogenesis in one family case. Methods One fam...">
<meta property="og:title" name="title" content="Frontiers | A Novel Germline Compound Heterozygous Mutation of BRCA2 Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings">
<meta property="og:description" name="description" content="Objectives To investigate the genetic variants that are responsible for peripheral neuroblastic tumors (PNTs) oncogenesis in one family case. Methods One fam...">
<meta name="keywords" content="peripheral neuroblastic tumors,Neuroblastoma,Ganglioneuroma,Whole- genome sequencing,RNA-Seq,BRCA2,Cancer predisposition gene">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="12">
<meta name="citation_journal_title" content="Frontiers in Genetics">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Genet.">
<meta name="citation_issn" content="1664-8021">
<meta name="citation_doi" content="10.3389/fgene.2021.652718">
<meta name="citation_firstpage" content="652718">
<meta name="citation_language" content="English">
<meta name="citation_title" content="A Novel Germline Compound Heterozygous Mutation of BRCA2 Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings">
<meta name="citation_keywords" content="peripheral neuroblastic tumors; Neuroblastoma; Ganglioneuroma; Whole- genome sequencing; RNA-Seq; BRCA2; Cancer predisposition gene">
<meta name="citation_abstract" content="Objectives To investigate the genetic variants that are responsible for peripheral neuroblastic tumors (PNTs) oncogenesis in one family case. Methods One family was recruited, including the healthy parents, sister affected by neuroblastoma (NB) and brother suffered from ganglioneuroma (GN). Whole-genome sequencing (WGS) of germline DNA from all the family members and RNA-seq of tumor RNA from the siblings were performed. Mutants were validated by Sanger sequencing and co-IP was performed to assess the impact of mutant on chemosensitivity in SH-SY5Y cell line. Results A novel compound heterozygous mutation of BRCA2 was locked as the cause of carcinogenesis. One allele was BRCA2-S871X (stop-gain) from the siblings mother, the other was BRCA2-N372H (missense) from their father. This novel compound heterozygous mutations of BRCA2 gene associated with PNTs by disordering DNA damage and response (DDR) signal pathway. Moreover, chemosensitivity was reduced in NB cell line due to BRCA2-N372H mutant. Conclusions In summary, these results revealed a novel germline compound heterozygous mutation of BRCA2 gene associated with familial PNTs.">
<meta name="citation_article_type" content="Original Research">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2021/05/31">
<meta name="citation_publication_date" content="2021/07/23">
<meta name="citation_author" content="Yang, Yeran ">
<meta name="citation_author_institution" content="Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China">
<meta name="citation_author" content="Chen, Jiwei ">
<meta name="citation_author_institution" content="Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, China">
<meta name="citation_author" content="Qin, Hong ">
<meta name="citation_author_institution" content="Department of Surgical Oncology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China">
<meta name="citation_author" content="Jin, Yaqiong ">
<meta name="citation_author_institution" content="Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China">
<meta name="citation_author" content="Zhang, Li ">
<meta name="citation_author_institution" content="Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, China">
<meta name="citation_author" content="Yang, Shen ">
<meta name="citation_author_institution" content="Department of Surgical Oncology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China">
<meta name="citation_author" content="Wang, Huanmin ">
<meta name="citation_author_institution" content="Department of Surgical Oncology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China">
<meta name="citation_author" content="Fu, Libing ">
<meta name="citation_author_institution" content="Department of Pathology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China">
<meta name="citation_author" content="Hong, Enyu ">
<meta name="citation_author_institution" content="Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China">
<meta name="citation_author" content="Yu, Yongbo ">
<meta name="citation_author_institution" content="Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China">
<meta name="citation_author" content="Lu, Jie ">
<meta name="citation_author_institution" content="Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China">
<meta name="citation_author" content="Chang, Yan ">
<meta name="citation_author_institution" content="Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China">
<meta name="citation_author" content="Ni, Xin ">
<meta name="citation_author_institution" content="Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China">
<meta name="citation_author" content="Xu, Min ">
<meta name="citation_author_institution" content="Department of Surgery, Shanghai Childrens Medical Center, School of Medicine, Shanghai Jiao Tong University, China">
<meta name="citation_author" content="Shi, Tieliu ">
<meta name="citation_author_institution" content="Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, China">
<meta name="citation_author" content="Guo, Yongli ">
<meta name="citation_author_institution" content="Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China">
<meta name="dc.identifier" content="doi:10.3389/fgene.2021.652718">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"A Novel Germline Compound Heterozygous Mutation of BRCA2 Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings","author":[{"@type":"Person","name":"Yeran Yang","affiliation":["Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Biobank for Clinical Data and Samples in Pediatric, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University, China"]},{"@type":"Person","name":"Jiwei Chen","affiliation":["Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, China"]},{"@type":"Person","name":"Hong Qin","affiliation":["Department of Surgical Oncology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China"]},{"@type":"Person","name":"Yaqiong Jin","affiliation":["Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Biobank for Clinical Data and Samples in Pediatric, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University, China"]},{"@type":"Person","name":"Li Zhang","affiliation":["Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, China"]},{"@type":"Person","name":"Shen Yang","affiliation":["Department of Surgical Oncology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China"]},{"@type":"Person","name":"Huanmin Wang","affiliation":["Department of Surgical Oncology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China"]},{"@type":"Person","name":"Libing Fu","affiliation":["Department of Pathology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China"]},{"@type":"Person","name":"Enyu Hong","affiliation":["Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Biobank for Clinical Data and Samples in Pediatric, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China"]},{"@type":"Person","name":"Yongbo Yu","affiliation":["Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Biobank for Clinical Data and Samples in Pediatric, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University, China"]},{"@type":"Person","name":"Jie Lu","affiliation":["Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Biobank for Clinical Data and Samples in Pediatric, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University, China"]},{"@type":"Person","name":"Yan Chang","affiliation":["Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Biobank for Clinical Data and Samples in Pediatric, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University, China"]},{"@type":"Person","name":"Xin Ni","affiliation":["Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Biobank for Clinical Data and Samples in Pediatric, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University, China"]},{"@type":"Person","name":"Min Xu","affiliation":["Department of Surgery, Shanghai Childrens Medical Center, School of Medicine, Shanghai Jiao Tong University, China"]},{"@type":"Person","name":"Tieliu Shi","affiliation":["Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, China"]},{"@type":"Person","name":"Yongli Guo","affiliation":["Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Biobank for Clinical Data and Samples in Pediatric, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China","Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University, China"]}],"datePublished":"2021-07-23","dateModified":"2025-11-25","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2021","isPartOf":{"@type":"PublicationVolume","volumeNumber":"12","isPartOf":{"@type":"Periodical","name":"Frontiers in Genetics"}}},"citation":["https://doi.org/10.3389/fgene.2021.652718"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="purple"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/genetics" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=30&amp;specialtyid=0&amp;entitytype=2&amp;entityid=240" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/genetics" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/applied-genetic-epidemiology" data-event="iBarJournal-sections-a_id_549">Applied Genetic Epidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/behavioral-and-psychiatric-genetics" data-event="iBarJournal-sections-a_id_536">Behavioral and Psychiatric Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cancer-genetics-and-oncogenomics" data-event="iBarJournal-sections-a_id_2030">Cancer Genetics and Oncogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/computational-genomics" data-event="iBarJournal-sections-a_id_551">Computational Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cytogenomics" data-event="iBarJournal-sections-a_id_2512">Cytogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/elsi-in-science-and-genetics" data-event="iBarJournal-sections-a_id_650">ELSI in Science and Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/epigenomics-and-epigenetics" data-event="iBarJournal-sections-a_id_455">Epigenomics and Epigenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/evolutionary-and-population-genetics" data-event="iBarJournal-sections-a_id_535">Evolutionary and Population Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-aging" data-event="iBarJournal-sections-a_id_596">Genetics of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-common-and-rare-diseases" data-event="iBarJournal-sections-a_id_635">Genetics of Common and Rare Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomic-assay-technology" data-event="iBarJournal-sections-a_id_557">Genomic Assay Technology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomics-of-plants-and-the-phytoecosystem" data-event="iBarJournal-sections-a_id_1520">Genomics of Plants and the Phytoecosystem</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/human-and-medical-genomics" data-event="iBarJournal-sections-a_id_1419">Human and Medical Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/immunogenetics" data-event="iBarJournal-sections-a_id_2237">Immunogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/livestock-genomics" data-event="iBarJournal-sections-a_id_241">Livestock Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/neurogenomics" data-event="iBarJournal-sections-a_id_19">Neurogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/nutritional-genomics" data-event="iBarJournal-sections-a_id_3423">Nutritional Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/predictive-toxicology-and-exposomics" data-event="iBarJournal-sections-a_id_556">Predictive Toxicology and Exposomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/rna" data-event="iBarJournal-sections-a_id_555">RNA</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/statistical-genetics-and-methodology" data-event="iBarJournal-sections-a_id_454">Statistical Genetics and Methodology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/stem-cell-research" data-event="iBarJournal-sections-a_id_685">Stem Cell Research</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=30&amp;specialtyid=0&amp;entitytype=2&amp;entityid=240" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/genetics" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/applied-genetic-epidemiology" data-event="iBarJournal-sections-a_id_549">Applied Genetic Epidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/behavioral-and-psychiatric-genetics" data-event="iBarJournal-sections-a_id_536">Behavioral and Psychiatric Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cancer-genetics-and-oncogenomics" data-event="iBarJournal-sections-a_id_2030">Cancer Genetics and Oncogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/computational-genomics" data-event="iBarJournal-sections-a_id_551">Computational Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cytogenomics" data-event="iBarJournal-sections-a_id_2512">Cytogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/elsi-in-science-and-genetics" data-event="iBarJournal-sections-a_id_650">ELSI in Science and Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/epigenomics-and-epigenetics" data-event="iBarJournal-sections-a_id_455">Epigenomics and Epigenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/evolutionary-and-population-genetics" data-event="iBarJournal-sections-a_id_535">Evolutionary and Population Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-aging" data-event="iBarJournal-sections-a_id_596">Genetics of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-common-and-rare-diseases" data-event="iBarJournal-sections-a_id_635">Genetics of Common and Rare Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomic-assay-technology" data-event="iBarJournal-sections-a_id_557">Genomic Assay Technology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomics-of-plants-and-the-phytoecosystem" data-event="iBarJournal-sections-a_id_1520">Genomics of Plants and the Phytoecosystem</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/human-and-medical-genomics" data-event="iBarJournal-sections-a_id_1419">Human and Medical Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/immunogenetics" data-event="iBarJournal-sections-a_id_2237">Immunogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/livestock-genomics" data-event="iBarJournal-sections-a_id_241">Livestock Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/neurogenomics" data-event="iBarJournal-sections-a_id_19">Neurogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/nutritional-genomics" data-event="iBarJournal-sections-a_id_3423">Nutritional Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/predictive-toxicology-and-exposomics" data-event="iBarJournal-sections-a_id_556">Predictive Toxicology and Exposomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/rna" data-event="iBarJournal-sections-a_id_555">RNA</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/statistical-genetics-and-methodology" data-event="iBarJournal-sections-a_id_454">Statistical Genetics and Methodology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/stem-cell-research" data-event="iBarJournal-sections-a_id_685">Stem Cell Research</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/genetics" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Genetics</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/applied-genetic-epidemiology" data-event="iBarJournal-sections-a_id_549">Applied Genetic Epidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/behavioral-and-psychiatric-genetics" data-event="iBarJournal-sections-a_id_536">Behavioral and Psychiatric Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cancer-genetics-and-oncogenomics" data-event="iBarJournal-sections-a_id_2030">Cancer Genetics and Oncogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/computational-genomics" data-event="iBarJournal-sections-a_id_551">Computational Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/cytogenomics" data-event="iBarJournal-sections-a_id_2512">Cytogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/elsi-in-science-and-genetics" data-event="iBarJournal-sections-a_id_650">ELSI in Science and Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/epigenomics-and-epigenetics" data-event="iBarJournal-sections-a_id_455">Epigenomics and Epigenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/evolutionary-and-population-genetics" data-event="iBarJournal-sections-a_id_535">Evolutionary and Population Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-aging" data-event="iBarJournal-sections-a_id_596">Genetics of Aging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genetics-of-common-and-rare-diseases" data-event="iBarJournal-sections-a_id_635">Genetics of Common and Rare Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomic-assay-technology" data-event="iBarJournal-sections-a_id_557">Genomic Assay Technology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/genomics-of-plants-and-the-phytoecosystem" data-event="iBarJournal-sections-a_id_1520">Genomics of Plants and the Phytoecosystem</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/human-and-medical-genomics" data-event="iBarJournal-sections-a_id_1419">Human and Medical Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/immunogenetics" data-event="iBarJournal-sections-a_id_2237">Immunogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/livestock-genomics" data-event="iBarJournal-sections-a_id_241">Livestock Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/neurogenomics" data-event="iBarJournal-sections-a_id_19">Neurogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/nutritional-genomics" data-event="iBarJournal-sections-a_id_3423">Nutritional Genomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/predictive-toxicology-and-exposomics" data-event="iBarJournal-sections-a_id_556">Predictive Toxicology and Exposomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/rna" data-event="iBarJournal-sections-a_id_555">RNA</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/statistical-genetics-and-methodology" data-event="iBarJournal-sections-a_id_454">Statistical Genetics and Methodology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/genetics/sections/stem-cell-research" data-event="iBarJournal-sections-a_id_685">Stem Cell Research</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/genetics/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=30&amp;specialtyid=0&amp;entitytype=2&amp;entityid=240" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Genet.</span><span>, 23 July 2021</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Genetics of Common and Rare Diseases</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 12 - 2021 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fgene.2021.652718">https://doi.org/10.3389/fgene.2021.652718</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">Emerging Technologies Powering Rare and Neglected Disease Diagnosis and Therapy Development</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 21 articles" href="https://www.frontiersin.org/research-topics/15957/emerging-technologies-powering-rare-and-neglected-disease-diagnosis-and-therapy-development/magazine" target="_self" data-event="customLink-linkType-a_viewAll21Articles"><span>View all 21 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>A Novel Germline Compound Heterozygous Mutation of <i>BRCA2</i> Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract">
<a id="h1" name="h1"></a>
<div class="authors"><span class="author-wrapper notranslate">
<a href="https://loop.frontiersin.org/people/963139" class="user-id-963139"><img class="pr5" src="https://loop.frontiersin.org/images/profile/963139/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="
Yeran Yang,,&#x;">Yeran Yang</a><sup>1,2,3&#x2020;</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/821216" class="user-id-821216"><img class="pr5" src="https://loop.frontiersin.org/images/profile/821216/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Jiwei Chen&#x;">Jiwei Chen</a><sup>4&#x2020;</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Hong Qin&#x;" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Hong Qin<sup>5&#x2020;</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/600699" class="user-id-600699"><img class="pr5" src="https://loop.frontiersin.org/images/profile/600699/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Yaqiong Jin,,">Yaqiong Jin</a><sup>1,2,3</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Li Zhang" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Li Zhang<sup>4</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/599994" class="user-id-599994"><img class="pr5" src="https://loop.frontiersin.org/images/profile/599994/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Shen Yang">Shen Yang</a><sup>5</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Huanmin Wang" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Huanmin Wang<sup>5</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Libing Fu" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Libing Fu<sup>6</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Enyu Hong," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Enyu Hong<sup>1,2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Yongbo Yu,," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Yongbo Yu<sup>1,2,3</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/1371032" class="user-id-1371032"><img class="pr5" src="https://loop.frontiersin.org/images/profile/1371032/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Jie Lu,,">Jie Lu</a><sup>1,2,3</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Yan Chang,," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Yan Chang<sup>1,2,3</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/925887" class="user-id-925887"><img class="pr5" src="https://loop.frontiersin.org/images/profile/925887/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Xin Ni,,">Xin Ni</a><sup>1,2,3</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Min Xu*" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Min Xu<sup>7*</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/557812" class="user-id-557812"><img class="pr5" src="https://loop.frontiersin.org/images/profile/557812/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Tieliu Shi*">Tieliu Shi</a><sup>4*</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/1155881" class="user-id-1155881"><img class="pr5" src="https://loop.frontiersin.org/images/profile/1155881/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Yongli Guo,,*">Yongli Guo</a><sup>1,2,3*</sup></span></div>
<ul class="notes">
<li><span><sup>1</sup></span>Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Children&#x2019;s Health, Beijing Children&#x2019;s Hospital, Beijing Pediatric Research Institute, Capital Medical University, Beijing, China</li>
<li><span><sup>2</sup></span>Biobank for Clinical Data and Samples in Pediatric, National Center for Children&#x2019;s Health, Beijing Children&#x2019;s Hospital, Beijing Pediatric Research Institute, Capital Medical University, Beijing, China</li>
<li><span><sup>3</sup></span>Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University, Beijing, China</li>
<li><span><sup>4</sup></span>Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, Shanghai, China</li>
<li><span><sup>5</sup></span>Department of Surgical Oncology, National Center for Children&#x2019;s Health, Beijing Children&#x2019;s Hospital, Capital Medical University, Beijing, China</li>
<li><span><sup>6</sup></span>Department of Pathology, National Center for Children&#x2019;s Health, Beijing Children&#x2019;s Hospital, Capital Medical University, Beijing, China</li>
<li><span><sup>7</sup></span>Department of Surgery, Shanghai Children&#x2019;s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China</li>
</ul>
<p class="mb15"><b>Objectives:</b> To investigate the genetic variants that are responsible for peripheral neuroblastic tumors (PNTs) oncogenesis in one family case.</p>
<p class="mb15"><b>Materials and Methods:</b> One family was recruited, including the healthy parents, sister affected by neuroblastoma (NB), and brother who suffered from ganglioneuroma (GN). Whole-genome sequencing (WGS) of germline DNA from all the family members and RNA-seq of tumor RNA from the siblings were performed. Mutants were validated by Sanger sequencing and co-IP was performed to assess the impact of the mutant on chemosensitivity in the SH-SY5Y cell line.</p>
<p class="mb15"><b>Results:</b> A novel compound heterozygous mutation of <i>BRCA2</i> was locked as the cause of carcinogenesis. One allele was BRCA2-S871X (stop-gain) from the siblings&#x2019; mother, the other was BRCA2-N372H (missense) from their father. This novel compound heterozygous mutations of the <i>BRCA2</i> gene associated with PNTs by disordering DNA damage and response (DDR) signal pathway. Moreover, chemosensitivity was reduced in the NB cell line due to the BRCA2-N372H mutant.</p>
<p class="mb0"><b>Conclusion:</b> In summary, these results revealed a novel germline compound heterozygous mutation of the <i>BRCA2</i> gene associated with familial PNTs.</p>
<div class="clear"></div>
</div>
<div class="JournalFullText">
<a id="h2" name="h2"></a><h2>Introduction</h2>
<p class="mb15">Peripheral neuroblastic tumors (PNTs), which account for 7&#x2013;10% of all tumors in children, arise from primitive sympathogonia (<a href="#B23">Luksch et al., 2016</a>). The PNTs encompass the histologic variants neuroblastoma (NB), ganglioneuroblastoma (GNB), and ganglioneuroma (GN). As tumors of the sympathetic nervous system, they arise wherever sympathetic tissue exists with a predilection for the adrenal gland and retro peritoneum. The biggest difference among these three tumors is the differentiation of tumor cells and prognosis. NB is the most undifferentiated and malignant tumor of the three. As a rare pediatric cancer, NB affects 10.2 per million children under 15 years of age and accounts for 15% of cancer deaths in children (<a href="#B5">Cheung and Dyer, 2013</a>). The most benign tumor is GN, which is composed of well-differentiated gangliocytes and mature stroma (<a href="#B21">Lonergan et al., 2002</a>). A familial history of NB is very rare, which is reported in about 1% of patients (<a href="#B14">Janoueix-Lerosey et al., 2010</a>). Missense and frameshift mutations of <i>PHOX2B</i> and activating mutations of <i>ALK</i> have been identified in NB families firstly (<a href="#B32">Trochet et al., 2004</a>; <a href="#B25">Mosse et al., 2008</a>). Furthermore, an increasing number of susceptibility genes have been observed in NB families, such as <i>NBPF1</i>, <i>NBPF23</i>, <i>BARD</i>, and <i>BRCA2</i> (<a href="#B28">Ritenour et al., 2018</a>).</p>
<p class="mb15">BRCA2 was first revealed to be involved in the homologous recombination (HR) repair pathway depending on interacting with the recombination protein RAD51. For DNA double-strand breaks (DSBs), HR is a high-fidelity mechanism of repair. As one of fifteen Fanconi anemia (FA) genes, BRCA2 also participates in the HR step in inter-strand crosslinks (ICLs) repair depending on RAD51. According to a previous study, about half of the cases of early-onset breast cancer are due to different inherited mutations in the <i>BRCA2</i> gene (<a href="#B33">Valencia et al., 2017</a>). In pediatrics, two BRCA2 germline mutations associated with NB have been reported to date. One is BRCA2 p. W2830_E20splice detected from 56 children with NB (<a href="#B38">Zhang et al., 2015</a>); the other is BRCA2 p. Y2215fs<sup>&#x2217;</sup> identified from one NB family (<a href="#B4">Cai et al., 2017</a>).</p>
<p class="mb0">In this study, a new compound heterozygous mutation of the <i>BRCA2</i> gene was discovered in two siblings with PNTs by applying WGS technology. One of the biallelic mutations was <i>BRCA2</i> rs397507634 chr13: 32911104C &#x003E; A (S871Ter), which was previously found from the screening of the BRCA1/2 genes (<a href="#B2">Alter, 2014</a>). However, there are no reports on the relationship between this stop-gain mutant and diseases including PNTs. The other was a missense mutant <i>BRCA2</i> rs144848 chr13:32906729A &#x003E; C (N372H). Although it was identified as highly related to breast cancer (<a href="#B12">Healey et al., 2000</a>), ovarian cancer (<a href="#B35">Wenham et al., 2003</a>), and other many kinds of cancers (<a href="#B30">Rudd et al., 2006</a>; <a href="#B27">Ramus et al., 2008</a>), there is no report on whether this missense mutant is associated with PNTs. The healthy parents harbored one different allele mutant of <i>BRCA2</i> separately. Unfortunately, the two children both inherited the two mutants from their parents and the novel compound heterozygous mutant of <i>BRCA2</i> led to PNTs. The evidence in this study may explain how both of the children suffer from the disease despite the absence of PNTs in their parents.</p>
<a id="h3" name="h3"></a><h2>Materials and Methods</h2>
<h3 class="pt0">Patients and Samples</h3>
<p class="mb0">This study included two young patients who were an elder sister (age at diagnosis was 30 months, II-1), and younger brother (age at diagnosis was 36 months, II-2), and their healthy parents (age at 30 s, I-1 and I-2), as shown in <a href="#F1">Figure 1A</a>. All patients&#x2019; parents signed informed consent and this study obtained approval from the Institution&#x2019;s Research Ethics Board of Hospital. DNeasy Blood and Tissue Kit (QIAGEN) was used for extracting genomic DNA from blood samples of the younger brother (II-2) and the parents (I-1 and I-2), and the tumor tissue of the siblings (II-1 and II-2). The elder sister&#x2019;s tissue DNA was substituted for her genomic DNA from blood to analyze germline mutants accompanying other family members because her blood was unavailable because she had passed away when this study was conducted. DNA concentration was measured by Qubit<sup>&#x00AE;</sup> DNA Assay Kit in Qubit<sup>&#x00AE;</sup> 2.0 Fluorometer (Life Technologies, Carlsbad, CA, United States). RNA of the two patients&#x2019; tumor tissue was extracted by TRzol (<a href="#B10">Geng et al., 2019</a>).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 1</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg" name="figure1" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg" alt="www.frontiersin.org" id="F1" loading="lazy">
  </picture>
</a>
<p><strong>Figure 1.</strong> The two-generation pedigree of the family and pathological diagnosis of the PNTs siblings. <b>(A)</b> Solid symbols (squares = males, circles = females) indicate clinically affected individuals, and open symbols indicate unaffected individuals. <b>(B)</b> Histological study confirmed the type of PNTs. II-1 shows the immature neuroblastic tissue from NB after chemotherapy (H&#x0026;E 100 &#x00D7;). II-2 shows mature ganglion cells with abundant cytoplasm in a GN (H&#x0026;E 50&#x00D7;).</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>Whole Genome Sequencing</h3>
<p class="mb0">A total of 0.5 &#x03BC;g of DNA per sample was used as input material for the DNA library preparations. Genomic libraries were prepared using the Illumina Truseq Nano DNA HT Sample Prep Kit following the manufacturer&#x2019;s instructions. Libraries were analyzed for size distribution by Agilent 2100 Bioanalyzer. The clustering of the index-coded samples was performed on a cBot Cluster Generation System using Hiseq X PE Cluster Kit V2.5 (Illumina, San Diego, CA, United States) according to the manufacturer&#x2019;s instructions. Then, the DNA libraries were sequenced on the Illumina Hiseq platform and 150 bp paired-end reads were generated.</p>
<h3>Read Mapping and Variant Calling</h3>
<p class="mb0">Reads after quality control were aligned to the UCSC human reference genome (GRCh37/hg19 assembly) using BWA 0.7.12-r1039 mem mode. Samtools-0.1.18 was used for sorting and removing PCR duplicates, and building an index for the bam files. Variants were called using the VarScan (version 2.3.9) pipeline (<a href="#B24">McKenna et al., 2010</a>).</p>
<h3>Variant Annotation and Prioritization</h3>
<p class="mb0">The resulting variants were annotated and prioritized by ANNOVAR (<a href="#B34">Wang et al., 2010</a>). A threshold of minor allele frequency (MAF &#x003C; 0.01) from the 1000 Genomes Project Asian (<a href="#B7">Devuyst, 2015</a>) and ExAC (<a href="#B18">Lek et al., 2016</a>) non-TCGA cohorts was used to screen rare variants. The pathogenicity of rare missense variants was evaluated by SIFT (<a href="#B19">Li and Durbin, 2009</a>), PolyPhen2 (<a href="#B1">Adzhubei et al., 2013</a>), MutationTaster (<a href="#B31">Schwarz et al., 2014</a>), and M-CAP (<a href="#B13">Jagadeesh et al., 2016</a>; <a href="#B20">Li et al., 2019</a>). Other rare variants, including frameshift, prematurely truncating, and initial codon variants were also retained for further analysis.</p>
<h3>Amplification and Sanger Sequencing of Mutation Sites</h3>
<p class="mb0">The two mutations in <i>BRCA2</i> were amplified by PCR with a Veriti 96-well Thermal Cycler (Applied Biosystems, Thermo Fisher Scientific). The primer sequences used were as follows: BRCA2-N372H (rs144848) F: 5&#x2032;-CTGAAGTGGAACCAAATGATACTGA-3&#x2032;, R: 5&#x2032;-AGACGGTACAACTTCCTTGGAGAT-3&#x2032; <a href="#B35">Wenham et al., 2003</a>); and BRCA2&#x2013;S871X (rs397507634) F: 5&#x2032;- AGTGGAATACAGTGATACTGAC -3&#x2032;, R: 5&#x2032;- TCGTTTACACAAGTCAAGTCTG -3&#x2032;. Mutations were confirmed by Sanger sequencing (<a href="#B3">Bao et al., 2019</a>).</p>
<h3>Differential Expression Analysis and KEGG Pathway Enrichment Analysis</h3>
<p class="mb0">RNA-seq data were aligned to the UCSC human reference genome (GRCh37/hg19 assembly) using Hisat2 2.0.1 (<a href="#B15">Kim et al., 2015</a>). Expression of genes (raw count) was quantified by StingTie 1.3.5 (<a href="#B26">Pertea et al., 2015</a>). Differentially expressed genes between different conditions were selected using R package DESeq2 based on the criteria of parameter: fold change &#x003E; 2 and FDR &#x003C; 0.05 (<a href="#B22">Love et al., 2014</a>). KEGG pathway enrichment analysis of differentially expressed genes was carried out using the R package clusterProfiler (<a href="#B37">Yu et al., 2012</a>). Only those pathways with adjusted <i>P</i>-value &#x003C; 0.05 were considered statistically significant.</p>
<h3>Plasmids and Reagents</h3>
<p class="mb15">The p3xFlag-GV141-P/CAF plasmid was purchased from Shanghai GeneChem Co., Ltd. The fragment of BRCA2-290-453aa-wildtype was cloned from pDEST26 -BRCA2 gifted from Dr. Dongyi Xu (Peking University). Using BM seamless cloning kit (Biomed, China), the truncation was cloned into pXJ40-HA. The construct with a mutation in BRCA2-290-453aa-N372H was generated as described previously (<a href="#B36">Yang et al., 2015</a>).</p>
<p class="mb0">Anti-Flag M2 agarose affinity gel and mouse monoclonal antibody against Flag was purchased from Sigma (St. Louis, MO, United States). Antibody against HA and antibody against 53BP1 were from Abcam.</p>
<h3>Cell Culture and Reagents</h3>
<p class="mb0">SH-SY5Y cells were obtained from the American Type Culture Collection (Rockville, MD, United States). The cell line was grown in DMEM medium supplemented with 10% fetal bovine serum at 37&#x00B0;C in the presence of 5% CO2. For transient transfection experiments, cells were transfected with indicated constructs, using Lipofectamin 3000 (Invitrogen) following the manufacturer&#x2019;s protocols.</p>
<h3>Coimmunoprecipitation and Western Blotting</h3>
<p class="mb0">SH-SY5Y cells transfected with p3xFlag-GV141-P/CAF and pXJ40-HA- BRCA2-290-453aa-WT or pXJ40-HA-BRCA2-290-453aa-N372H were harvested and immunoprecipitation with anti-Flag M2 agarose was performed using whole cell lysates as described previously (<a href="#B34">Wang et al., 2010</a>). For the drug treatment group, 1 &#x03BC;M final concentration of Adriamycin (ADR) (Sigma) was added into the cell culture medium for 6 h before harvesting the whole cell lysis. Samples were separated by SDS-PAGE and detected by immunoblotting with indicated antibodies.</p>
<a id="h4" name="h4"></a><h2>Results</h2>
<h3 class="pt0">Clinical Features</h3>
<p class="mb0">A 30-month-old Chinese girl (the proband, elder sister, and II-1; <a href="#F1">Figure 1</a>) was diagnosed with NB, which primary site was retroperitoneum, in Shanghai Children&#x2019;s Medical Center (SCMC) Affiliated to Shanghai Jiao Tong University. Serum neuron-specific enolase (NSE), serum lactate dehydrogenase (LDH), urinary vanillylmandelic acid (VMA), and urinary homovanillic acid (HVA) were all significantly elevated. The patient was diagnosed with high risk NB at stage M, with metastasis to bone and bone marrow, according to the international Neuroblastoma Risk Group (INRG) staging and risk system. Complying with SCMC-NB-2009 treatment protocol (<a href="#B4">Cai et al., 2017</a>), the proband was treated with chemotherapy before removing the primary tumor. After surgery, the proband was determined to be NB by pathological examination (<a href="#F1">Figure 1B</a>) according to international Neuroblastoma Pathology Classification (INPC). <i>MYCN</i> status, 1p36, and 11q23 were all normal without amplification or deletion. Although the myeloablative therapy, autologous stem cell transplant, radiation, and isotretinoin were following applied, the girl was recurrent after 26 months from the first diagnosis with NB. Then the proband accepted additional chemotherapy and allogeneic hematopoietic stem cell transplantation. Unfortunately, the patient died 53 months after the final onset of illness (<a href="#T1">Table 1</a>).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">TABLE 1</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg" name="table1" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg" alt="www.frontiersin.org" id="T1" loading="lazy">
  </picture>
</a>
<p><strong>Table 1.</strong> Clinical characteristics of two patients with peripheral neuroblastic tumors.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb15 w100pc float_left mt15">The second case was the proband&#x2019;s younger brother (63 months younger than his sister, II-2, and <a href="#F1">Figure 1</a>). He was 36 months old at the time of diagnosis with GN, which is the same origin as NB but one benign type of PNTs in Beijing Children Hospital Affiliated with Capital Medical University. Unlike his sister, the tumor was in the adrenal gland. Serum NSE, serum LDH, urinary VMA, and urinary HVA were all normal. Besides, <i>MYCN</i> status, 1p36, and 11q23 were also normal without amplification or deletion, which was the same as his sister. The patient was diagnosed with very low risk GN at stage L1, according to the INRG staging and risk system. On account of this being a benign tumor, the treatment schedule only included surgery and observation, and no recurrence as yet (<a href="#T1">Table 1</a>).</p>
<p class="mb0">Information on the three generations of this family was collected. The grandfather of the proband died from liver cancer, and the grandmother is alive but suffering from gastric carcinoma and thyroid cancer. The maternal grandfather of the proband had Alzheimer&#x2019;s, and the maternal grandmother lives with benign thyroid nodules. Other family members are healthy, including the father&#x2019;s sister and her two children. The parents stated normal pregnancies and deliveries without any adverse event for the siblings.</p>
<h3>Whole-Genome Sequencing Analysis and Pathogenic Variants Validating</h3>
<p class="mb15">The fact that the siblings in the same family suffered from PNTs strongly suggested that their carcinogenesis was caused by germline variants. Therefore, to identify the causative variants contributing to the carcinogenesis, we performed high-coverage and high-quality WGS of all family members (father, mother, sister, and brother). Specifically, more than 91.4% of the whole genome had 10-fold coverage and showed high consistency among the experiments. In addition, more than 89% of sequenced bases reached Q<sub>30</sub> based on the analysis of the Phred-scaled quality score (<a href="#S12">Supplementary Tables 1</a>, <a href="#S12">2</a>).</p>
<p class="mb0">The variant calling analysis identified about 4.4 million variants in each family member (<a href="#S12">Supplementary Table 2</a>). Of these, a total of shared 47088 rare variants of the siblings and their mother were selected based on MAF &#x003C; 0.01. Furthermore, exonic non-synonymous variants were analyzed and 185 rare variants inherited from the mother were selected. Finally, among rare variants from the mother, as cancer driver genes, a missense mutant <i>ALK</i> (chr2: 30143039G &#x003E; T, V163L, rs55697431), and a stop-gain mutant <i>BRCA2</i> (chr13: 32911104C &#x003E; A, S871Ter, rs397507634) were focused through screening using the IntOGen database (<a href="#F2">Figure 2A</a>). For ALK-V163L, multiple databases predicted that it was a benign mutation although <i>ALK</i> is one of the most famous susceptibility genes for NB (<a href="#S12">Supplementary Table 3</a>).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 2</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg" name="figure2" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg" alt="www.frontiersin.org" id="F2" loading="lazy">
  </picture>
</a>
<p><strong>Figure 2.</strong> <b>(A)</b> Workflow for the identification of pathogenic mutations. <b>(B)</b> Schematic diagram of genetic pattern.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb15 w100pc float_left mt15">Meanwhile, the same strategy was performed to select shared rare variants of the siblings and their father (<a href="#F2">Figure 2A</a>). However, there was no same gene between the mother and father by this strategy (data not shown). Knudson&#x2019;s &#x201C;two-hit&#x201D; theory, one susceptibility gene carried different mutants from mother and father separately. Further analysis revealed that they shared total variants gained from father (no MAF value limitation), and a missense mutant <i>BRCA2</i> (chr13:32906729A &#x003E; C, N372H, rs144848) was selected. Although BRCA2-N372H is a common variant (C = 0.279642, GnomAD_exome) inherited from the father, it induced a novel compound heterozygous mutation of <i>BRCA2</i>, and combining with a stop-gain mutant BRCA2-S871Ter inherited from the mother. In other words, one allele was BRCA2-S871Ter (stop-gain) from the sibling&#x2019;s mother, and the other was BRCA2-N372H (missense) from the father (<a href="#F2">Figure 2B</a> and <a href="#S12">Supplementary Table 3</a>). These two mutants of <i>BRCA2</i> were confirmed in the four persons by Sanger sequencing (<a href="#F3">Figure 3A</a>). In a word, the novel compound heterozygous mutation <i>BRCA2</i> gene was locked as the cause of carcinogenesis.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 3</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg" name="figure3" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg" alt="www.frontiersin.org" id="F3" loading="lazy">
  </picture>
</a>
<p><strong>Figure 3.</strong> Sanger sequencing validation and functional domains of full-length and mutant BRCA2 protein. <b>(A)</b> Sanger sequencing confirmed the mutations of <i>BRCA2</i>. The two patients (II-1 and II-2) carried both of these two variants. The father carried BRCA2-N372H, while the mother carried BRCA2-S871Ter. <b>(B)</b> The full-length BRCA2 protein harbors six functional domains, including PALB2 binding domain, P/CAF binding domain, BRCTs repeat region, Helical domain, OB folds, and TR2 domain. BRCA2-N372H mutant is in the P/CAF binding domain; while the BRCA2-S871Ter variant results in premature truncation at the 871st amino acid of BRCA2 protein, which only includes the PALB2 and P/CAF binding domains.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>BRCA2-S871Ter Mutant Mechanistic Association With PNTs</h3>
<p class="mb15">As a stop-gain mutation, rs397507634 (S871Ter) in <i>BRCA2</i> was found first by quantitative polymerase chain reaction and high-resolution melting curve analysis (<a href="#B6">Coulet et al., 2010</a>). This variation resulted in premature truncation at the 871st amino acid of the BRCA2 protein, which only includes the PALB2 and P/CAF binding domains (<a href="#F3">Figure 3B</a>). Based on ClinVar annotation, rs397507634 in <i>BRCA2</i> is related to hereditary breast and ovarian cancer syndrome (RCV000590670.1), breast-ovarian cancer, familial 2 (RCV000077282.4), and hereditary cancer-predisposing syndrome (RCV000213349.1).</p>
<p class="mb0">By mining for the potential impact of stop-gain mutant BRCA2-S871Ter, differentially expressed genes were obtained from RNA-seq data of patients&#x2019; tumor tissue (<a href="#S12">Supplementary Table 4</a>) and the GEO database GSE62564. There are four samples carrying BRCA2-N372H without BRCA2-S871Ter in the GSE62564 database, including three samples with homozygous mutant (NB_380, NB_390, and NB_438) and one sample with heterozygous mutant (NB_459). KEGG pathway enrichment analysis based on differential genes was performed between siblings and these four samples from the GSE62564 database. The result showed that the significant enriched KEGG pathway included DNA replication, cell cycle, and HR, which were identified with the molecular functions of BRCA2 (<a href="#F4">Figure 4A</a>).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 4</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg" name="figure4" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg" alt="www.frontiersin.org" id="F4" loading="lazy">
  </picture>
</a>
<p><strong>Figure 4.</strong> KEGG pathway enrichment analysis of differentially expressed genes. <b>(A)</b> To analyze the contribution of stop-gain mutant BRCA2-S871Ter, analysis based on differential genes obtaining from RNA-seq data was performed between siblings and four samples with BRCA2-N372H variant belonging to the GSE62564 database. <b>(B)</b> To reveal whether the compound heterozygous mutant of <i>BRCA2</i> contributed to the PNTs, we compared the siblings&#x2019; RNA-seq data, and 494 cases without either BRCA2-N372H or S871Ter mutant from the GSE62564 database.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb15 w100pc float_left mt15">Besides, BRCA2-S871Ter led to early termination during BRCA2 protein translation and produced a 1&#x2013;871 amino acid truncation of BRCA2 or even led to degradation of BRCA2. To simulate the functions of BRCA2-S871Ter, the GSE62564 dataset (498 samples) was analyzed. Samples with the top 25% (BRCA2 high group) and the lowest 25% (BRCA2 low group) expression of <i>BRCA2</i> were taken separately. KEGG pathway enrichment analysis based on these two groups was performed (<a href="#S12">Supplementary Figure 1</a>). The results also revealed that pathways of the cell cycle, DNA replication, and HR were enriched significantly.</p>
<h3>BRCA2-N372H Mutant Mechanistic Association With PNTs</h3>
<p class="mb0">In addition to the BRCA2 premature truncating mutant, a missense variant rs144848 (N372H) of <i>BRCA2</i> inherited from proband&#x2019;s mother was considered a pathogenic variant. It has been reported to increase the risk of many kinds of cancers, especially breast and epithelial ovarian, and indicating that the variant could increase cancer susceptibility. However, there was no report that BRCA2-N372H was associated with neuroblastic tumors. This mutant locates in the P/CAF binding domain (residues 290&#x2013;453) of BRCA2 (<a href="#F3">Figure 3B</a>). This domain has been shown to mediate the interaction between BRCA2 and the histone acetyltransferase P/CAF. The formation of the BRCA2-P/CAF complex is essential for the transcriptional activation of other genes (<a href="#B9">Fuks et al., 1998</a>). Co-IP was performed and showed that BRCA2-N372H substitution did not affect the interaction between BRCA2 and P/CAF absenting chemotherapeutics drug (<a href="#F5">Figure 5B</a>). To determine the optimum concentration and time of treatment with ADR, SH-SY5Y was treated with 1 &#x03BC;M ADR at a different time and then detected the expression of 53BP1 by WB. The results showed that 1 &#x03BC;M ADR treated for 6 h could induce the expression of 53BP1, which was enhanced significantly (<a href="#F5">Figure 5A</a>). Remarkably, after the same condition of ADR treatment (1 &#x03BC;M, 6 h), the interaction between BRCA2 and P/CAF was reduced significantly due to the N372H mutant in the SH-SY5Y cell line (<a href="#F5">Figure 5B</a>). The results suggest that the BRCA2-N372H mutant could destroy the function of P/CAF in the context of DNA damage.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 5</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg" name="figure5" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg" alt="www.frontiersin.org" id="F5" loading="lazy">
  </picture>
</a>
<p><strong>Figure 5.</strong> Co-IP between BRCA2 and P/CAF. <b>(A)</b> The optimum concentration and time of treatment with ADR in SH-SY5Y to induce DNA double-strand breaks. 1 &#x03BC;M ADR treated with 6 h could induce the expression of 53 bp1 enhanced significantly. <b>(B)</b> Co-IP showed that BRCA2-N372H substitution reduced the interaction between BRCA2 and P/CAF with the treatment of ADR (1 &#x03BC;M and 6 h). SH-SY5Y cells were transfected with plasmids expressing Flag-p/CAF and HA-BRCA2-266-453-WT or HA-BRCA2-266-453-N372H and analyzed by co-IP with or without ADR treatment. Immunoprecipitates were analyzed by western blot with antibodies against Flag or HA.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>Dysfunctional BRCA2 Due to <i>BRCA2</i> Mutants</h3>
<p class="mb15">To reveal the compound heterozygous of <i>BRCA2</i> was contributed to PNTs&#x2019; carcinogenesis, KEGG pathway enrichment analysis was performed between the siblings&#x2019; RNA-seq data and 494 cases without either BRCA2-S871Ter or BRCA2-N372H mutants from the GSE62564 database. It was shown that the pathways of the cell cycle, DNA replication, FA pathway, and HR were enriched. (<a href="#F4">Figure 4B</a>). It indicated that the compound heterozygous of <i>BRCA2</i> resulted in the disordering of BRCA2 protein&#x2019;s function of DNA damage and response (DDR), which was the reason two child patients suffered PNTs.</p>
<p class="mb0">To simulate the functions of the new compound heterozygous of <i>BRCA2</i>, the GSE62564 dataset (498 samples) was analyzed and the one intersection of samples with the top 25% expression of both <i>BRCA2</i> and <i>P/CAF</i> (BRCA2-P/CAF high group, 36 samples) was taken. Meanwhile, samples with the lowest 25% expression of both <i>BRCA2</i> and <i>P/CAF</i> were taken as the other intersection from GSE62564 (BRCA2-P/CAF low group, 39 samples). KEGG pathway enrichment analysis was performed between the two intersections (<a href="#S12">Supplementary Figure 2</a>). The results also revealed that pathways of the cell cycle, DNA replication, FA pathway, and HR pathways were enriched significantly, which was similar to our previous results (<a href="#F4">Figure 4B</a>).</p>
<a id="h5" name="h5"></a><h2>Discussion</h2>
<p class="mb15"><i>BRCA2</i>, a principal tumor suppressor gene, is involved in DNA damage repair and related to many types of cancer susceptibility, especially breast cancer, and ovarian cancer in adults (<a href="#B29">Rousset-Jablonski and Gompel, 2017</a>; <a href="#B8">Flaum et al., 2019</a>). Meanwhile, as one of the FA DNA repair-related genes, some specific <i>BRCA2</i> mutants lead to a severe subset FA accompanying the early onset of cancer, including acute myeloid leukemia, brain tumors, Wilms tumor, and so on (<a href="#B2">Alter, 2014</a>). In pediatrics, BRCA2 p. W2830_E20splice and p. Y2215fs<sup>&#x2217;</sup> are the only two <i>BRCA2</i> germline mutations to have been reported to associate with NB (<a href="#B38">Zhang et al., 2015</a>; <a href="#B4">Cai et al., 2017</a>).</p>
<p class="mb15">This study revealed a new compound heterozygotes mutant of <i>BRCA2</i> by employing WGS of germline DNA in two siblings with PNTs and their unaffected parents. A stop-gain mutant BRCA2-S871Ter inherited from the mother and a missense mutant BRCA2-N372H inherited from the father were validated by Sanger sequencing (<a href="#F3">Figure 3A</a>). According to Knudson&#x2019;s &#x201C;two-hit&#x201D; theory (<a href="#B16">Knudson, 1996</a>) and KEGG pathway enrichment analysis (<a href="#F4">Figure 4B</a> and <a href="#S12">Supplementary Figure 2</a>), our results provide useful information that this novel compound heterozygotes mutant of <i>BRCA2</i> could be the cause of carcinogenesis and a potential biomarker for PNTs.</p>
<p class="mb15">For the stop-gain mutant, inherited from the mother of the siblings, BRCA2-S871Ter is a rare frequency variation, which has been found through qPCR-HRM based on 210 patients (<a href="#B6">Coulet et al., 2010</a>). Moreover, this variation is included in some panels to detect breast cancer or ovarian cancer in clinical settings. It can lead to early termination during BRCA2 protein translation and produce a 1&#x2013;871 amino acids truncation of BRCA2. In this study, western blotting was performed to detect BRCA2 expression in the siblings&#x2019; tumor tissue. Unfortunately, there was no specific signal of BRCA2 in WB (data not shown). The reason for failing to detect BRCA2 might be protein degradation for its large molecular weight. Although it is not certain whether this truncation is expressed or degraded after translation, the fact is that the functions of BRCA2 should be impacted to a great extent. As <a href="#F3">Figure 3B</a> shows, the majority of the important domains, including BRCTs domain, helical domain, OB folds, and the TR2 domain, are not in the BRCA2 stop-gain truncation. These domains all play key roles in DNA double strand breaks repair. The BRCTs and OB fold domain are essential to BRCA2 binding to RAD51. Then the BRCA2-RAD51 complex will further promote RAD51 assembly onto single-strand DNA to carry forward HR repair. KEGG pathway enrichment analysis also confirmed the above results about BRCA2-S871Ter (<a href="#F4">Figure 4A</a> and <a href="#S12">Supplementary Figure 1</a>).</p>
<p class="mb15">In addition, BRCA2-N372H is a variant associated with breast cancer and epithelial ovarian cancer (<a href="#B12">Healey et al., 2000</a>; <a href="#B35">Wenham et al., 2003</a>). Recently, an increasing number of studies have been performed to prove that the BRCA2-N372H variant is related to susceptibility to many other cancers, including multiple lymphoma, prostate cancer, advanced esophageal squamous cell carcinoma, familial colorectal tumors, and so on. Moreover, previous research has shown that BRCA2-N372H is located in the P/CAF binding domain of BRCA2. The domain from residues of amino acid 290&#x2013;453 in the N-terminus of BRCA2 specifically interacts with the histone acetyltransferase P/CAF (<a href="#B9">Fuks et al., 1998</a>). P/CAF belongs to the type three family of lysine acetyl transferases (KAT3) (<a href="#B11">Goodman and Smolik, 2000</a>). As a transcriptional co-activator, P/CAF binds to transcription factors and performs lysine acetyltransferases activity to acetylate these transcription factors and histones to lose condensed chromosomes. N terminus of BRCA2 is equipped with HAT activity when it bounds to P/CAF. The BRCA2-N372H variation weakens BRCA2 expression and BRCA2-P/CAF interaction and further reduces sensitivity to paclitaxel in breast cancer cells (<a href="#B17">Kwon et al., 2017</a>). It indicates that BRCA2 372-His substitution induces sequential changes of BRCA2-P/CAF interaction and HAT activity, which is important in paclitaxel resistance (<a href="#B17">Kwon et al., 2017</a>). ADR as the first-line chemotherapy drug to NB therapy could induce DSBs to NB cells. In our study, with ADR treatment, the interaction between BRCA2, and P/CAF was reduced significantly due to the N372H mutant in SH-SY5Y cells (<a href="#F5">Figure 5</a>). Meanwhile, BRCA2-N372H substitution could not affect the interaction between BRCA2 and P/CAF without drugs. The results suggested that the BRCA2-N372H mutant could destroy the HAT activity of BRCA2-P/CAF in the context of DNA damage. Furthermore, like the paclitaxel resistance, this mutant could induce ADR resistance to NB cells due to lack of HAT activity. This indicates that the BRCA2-N372H mutant could be a new potential drug target in NB chemotherapy.</p>
<p class="mb0">This study explored the reason for different malignant degrees between these two child patients. Firstly, the BRCA2-N372H variant was reported to affect fetal survival in a sex-dependent manner. With the same BRCA2-N372H variant, the survival rate of newborn females was significantly lower than males (<a href="#B12">Healey et al., 2000</a>). Secondly, WGS of the two children&#x2019;s tumor tissue did not show enrichment of any distinct carcinogenesis related pathway in specific somatic variants in the siblings, respectively (<a href="#S12">Supplementary Figure 2</a>). There were 721 individual mutant genes in the elder sister and 701 individual mutant genes in the brother. However, screening the IntOGen database revealed that the elder sister harbored more specific cancer driver genes than a brother (20 vs. 14 genes), indicating that the sister had a greater chance of developing a malignant tumor (<a href="#S12">Supplementary Tables 6,7</a>). Furthermore, RNA-seq analysis based on the two siblings&#x2019; tissue RNA revealed that the row counts of <i>BRCA2</i> mRNA expression were 91 in the sister and 898 in the brother (<a href="#S12">Supplementary Table 5</a>). Real-time PCR was performed to confirm the relative expression of <i>BRCA2</i> in the siblings&#x2019; tumor tissue. It was verified that the expression of <i>BRCA2</i> in the sister was significantly lower than in the younger brother (<a href="#S12">Supplementary Figure 3</a>). Although the sample size was limited in this study, the siblings harbored similar genetic backgrounds and the same compound heterozygous mutation of <i>BRCA2</i>. This indicated that as tumor suppressor genes, a low amount of BRCA2 may lead to cancer susceptibility, and therefore the malignancy degree in the sister was higher than the younger brother. However, the mechanism of different malignant degrees between the siblings needs further study.</p>
<a id="h6" name="h6"></a><h2>Conclusion</h2>
<p class="mb0">Our data revealed that a novel compound heterozygous mutation of the <i>BRCA2</i> gene is associated with PNTs by disordering DDR signal pathway. One allele was stop-gain mutant BRCA2-S871Ter, inherited from their mother. The other was a missense mutant BRCA2-N372H inherited from their father, which was confirmed to impair the interaction between BRCA2 and P/CAF, and induced ADR resistance in NB. Moreover, these results provided potential laboratory evidence for the clinical and prenatal diagnosis of PNTs. These results could also potentially guide clinical precision medication. For further investigation of the genotype-phenotype relationship in PNTs, future efforts should be made to recruit more families affected by this disease, and despite its rarity.</p>
<a id="h7" name="h7"></a><h2>Limitations</h2>
<p class="mb0">There were some limitations in the present study. Firstly, the sample size was small, due to the study object was only one family with two siblings harboring PNTs. Secondly, we needed to make a credible conclusion by incorporating prior knowledge, because of the rarity of samples. Therefore, to further investigate the genotype-phenotype relationship in PNTs, efforts should be made to recruit more families affected by this disease. Furthermore, to decipher the molecular mechanism of the compound heterozygous of <i>BRCA2</i> mutations, more studies, including cell level and animal models, and need to be performed in the future.</p>
<a id="h8" name="h8"></a><h2>Data Availability Statement</h2>
<p class="mb0">The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <a href="https://www.biosino.org/node/analysis/detail/OEZ005703">https://www.biosino.org/node/analysis/detail/OEZ005703</a>, OEZ005703.</p>
<a id="h9" name="h9"></a><h2>Ethics Statement</h2>
<p class="mb0">The studies involving human participants were reviewed and approved by Ethics Committee of the Beijing Children&#x2019;s Hospital, Capital Medical University. Written informed consent to participate in this study was provided by the participants&#x2019; legal guardian/next of kin. Written informed consent was obtained from the individual(s), and minor(s)&#x2019; legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.</p>
<a id="S9" name="S9"></a><h2>Author Contributions</h2>
<p class="mb0">YrY, JC, and HQ conducted the experiments, analyzed the data, and wrote the manuscript. YJ and LZ analyzed the data, reviewed, and edited the manuscript. SY, HW, LF, EH, YbY, JL, YC, and XN conducted the experiments. MX, TS, and YG designed the study, wrote, reviewed, and edited the manuscript, and administrated the project. All authors contributed to the article and approved the submitted version.</p>
<a id="fun1" name="fun1"></a><h2>Funding</h2>
<p class="mb0">This study was supported by the National Natural Science Foundation of China (81702787, 81702463, and 31671377), the Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Hospitals Authority (No. XTCX201806), Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (XMLX202121), Beijing Hospitals Authority&#x2019; Ascent Plan (DFL20191201), and Shanghai Municipal Science and Technology Major Project (2017SHZDZX01).</p>
<a id="conf1" name="conf1"></a><h2>Conflict of Interest</h2>
<p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<a id="h13" name="h13"></a><h2>Publisher&#x2019;s Note</h2>
<p class="mb0">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
<a id="ack1" name="ack1"></a><h2>Acknowledgments</h2>
<p class="mb0">We are grateful to the child patients and their parents for their participation in this study.</p>
<a id="S12" name="S12"></a><h2>Supplementary Material</h2>
<p class="mb15">The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fgene.2021.652718/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2021.652718/full#supplementary-material</a></p>
<p class="mb15" id="FS1"><b>Supplementary Figure 1 &#x007C;</b> KEGG pathway enrichment analysis of differentially expressed genes between BRCA2 high group and BRCA2 low group from GSE62564 dataset.</p>
<p class="mb15" id="FS2"><b>Supplementary Figure 2 &#x007C;</b> KEGG pathway enrichment analysis of differentially expressed genes between BRCA2-P/CAF high group and BRCA2-P/CAF low group from GSE62564 dataset.</p>
<p class="mb15" id="FS3"><b>Supplementary Figure 3 &#x007C;</b> KEGG pathway enrichment analysis of specific somatic variants. <b>(A)</b> KEGG pathway enrichment of 721 individual mutant genes in elder sister. <b>(B)</b> KEGG pathway enrichment of 701 individual mutant genes in brother.</p>
<p class="mb0" id="FS4"><b>Supplementary Figure 4 &#x007C;</b> Expression of <i>BRCA2</i> in the siblings. Real-time PCR to detect expression of <i>BRCA2</i> in the siblings&#x2019; RNA from tumor tissue.</p>
<a id="refer1" name="refer1"></a><h2>References</h2>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B1" id="B1"></a>Adzhubei, I., Jordan, D. M., and Sunyaev, S. R. (2013). Predicting functional effect of human missense mutations using PolyPhen-2. <i>Curr. Protoc. Hum. Genet.</i> Chapter 7:Unit7.20.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Predicting+functional+effect+of+human+missense+mutations+using+PolyPhen-2%2E&#x0026;journal=Curr%2E+Protoc%2E+Hum%2E+Genet%2E&#x0026;author=Adzhubei+I.&#x0026;author=Jordan+D.+M.&#x0026;author=Sunyaev+S.+R.&#x0026;publication_year=2013&#x0026;volume=Chapter 7&#x0026;issue=Unit7.20" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B2" id="B2"></a>Alter, B. P. (2014). Fanconi anemia and the development of leukemia. <i>Best Pract. Res. Clin. Haematol.</i> 27, 214&#x2013;221.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Fanconi+anemia+and+the+development+of+leukemia%2E&#x0026;journal=Best+Pract%2E+Res%2E+Clin%2E+Haematol%2E&#x0026;author=Alter+B.+P.&#x0026;publication_year=2014&#x0026;volume=27&#x0026;pages=214&#x2013;221" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B3" id="B3"></a>Bao, Y., Suo, L., Qian, P., Huang, H., Yang, Y., Tang, J., et al. (2019). Clinical and genetic analysis of Dent disease with nephrotic range albuminuria in Shaanxi, China. <i>Sci. China Life Sci.</i> 62, 1590&#x2013;1593. doi: 10.1007/s11427-018-9829-0</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31701402" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s11427-018-9829-0" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Clinical+and+genetic+analysis+of+Dent+disease+with+nephrotic+range+albuminuria+in+Shaanxi%2C+China%2E&#x0026;journal=Sci%2E+China+Life+Sci%2E&#x0026;author=Bao+Y.&#x0026;author=Suo+L.&#x0026;author=Qian+P.&#x0026;author=Huang+H.&#x0026;author=Yang+Y.&#x0026;author=Tang+J.&#x0026;publication_year=2019&#x0026;volume=62&#x0026;pages=1590&#x2013;1593" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B4" id="B4"></a>Cai, J., Pan, C., Tang, Y., Chen, J., Zhou, M., Li, B., et al. (2017). Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China. <i>J. Cancer Res. Clin. Oncol.</i> 143, 1327&#x2013;1335. doi: 10.1007/s00432-017-2379-5</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28283783" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00432-017-2379-5" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Multivariate+analysis+of+risk+factors+for+patients+with+stage+4+neuroblastoma+who+were+older+than+18+months+at+diagnosis%3A+a+report+from+a+single+institute+in+Shanghai%2C+China%2E&#x0026;journal=J%2E+Cancer+Res%2E+Clin%2E+Oncol%2E&#x0026;author=Cai+J.&#x0026;author=Pan+C.&#x0026;author=Tang+Y.&#x0026;author=Chen+J.&#x0026;author=Zhou+M.&#x0026;author=Li+B.&#x0026;publication_year=2017&#x0026;volume=143&#x0026;pages=1327&#x2013;1335" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B5" id="B5"></a>Cheung, N. K., and Dyer, M. A. (2013). Neuroblastoma: developmental biology, cancer genomics and immunotherapy. <i>Nat. Rev. Cancer</i> 13, 397&#x2013;411. doi: 10.1038/nrc3526</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23702928" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrc3526" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Neuroblastoma%3A+developmental+biology%2C+cancer+genomics+and+immunotherapy%2E&#x0026;journal=Nat%2E+Rev%2E+Cancer&#x0026;author=Cheung+N.+K.&#x0026;author=Dyer+M.+A.&#x0026;publication_year=2013&#x0026;volume=13&#x0026;pages=397&#x2013;411" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B6" id="B6"></a>Coulet, F., Pires, F., Rouleau, E., Lefol, C., Martin, S., Colas, C., et al. (2010). A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis. <i>Genet. Test Mol. Biomark.</i> 14, 677&#x2013;690. doi: 10.1089/gtmb.2009.0183</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20858050" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1089/gtmb.2009.0183" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=A+one-step+prescreening+for+point+mutations+and+large+rearrangement+in+BRCA1+and+BRCA2+genes+using+quantitative+polymerase+chain+reaction+and+high-resolution+melting+curve+analysis%2E&#x0026;journal=Genet%2E+Test+Mol%2E+Biomark%2E&#x0026;author=Coulet+F.&#x0026;author=Pires+F.&#x0026;author=Rouleau+E.&#x0026;author=Lefol+C.&#x0026;author=Martin+S.&#x0026;author=Colas+C.&#x0026;publication_year=2010&#x0026;volume=14&#x0026;pages=677&#x2013;690" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B7" id="B7"></a>Devuyst, O. (2015). The 1000 genomes project: welcome to a new world. <i>Perit. Dial. Int.</i> 35, 676&#x2013;677. doi: 10.3747/pdi.2015.00261</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26703842" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3747/pdi.2015.00261" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=The+1000+genomes+project%3A+welcome+to+a+new+world%2E&#x0026;journal=Perit%2E+Dial%2E+Int%2E&#x0026;author=Devuyst+O.&#x0026;publication_year=2015&#x0026;volume=35&#x0026;pages=676&#x2013;677" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B8" id="B8"></a>Flaum, N., Crosbie, E. J., Edmondson, R. J., Smith, M. J., and Evans, D. G. (2019). Epithelial ovarian cancer risk: a review of the current genetic landscape. <i>Clin. Genet.</i> 97, 54&#x2013;63. doi: 10.1111/cge.13566</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31099061" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/cge.13566" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Epithelial+ovarian+cancer+risk%3A+a+review+of+the+current+genetic+landscape%2E&#x0026;journal=Clin%2E+Genet%2E&#x0026;author=Flaum+N.&#x0026;author=Crosbie+E.+J.&#x0026;author=Edmondson+R.+J.&#x0026;author=Smith+M.+J.&#x0026;author=Evans+D.+G.&#x0026;publication_year=2019&#x0026;volume=97&#x0026;pages=54&#x2013;63" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B9" id="B9"></a>Fuks, F., Milner, J., and Kouzarides, T. (1998). BRCA2 associates with acetyltransferase activity when bound to P/CAF. <i>Oncogene</i> 17, 2531&#x2013;2534. doi: 10.1038/sj.onc.1202475</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/9824164" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.onc.1202475" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=BRCA2+associates+with+acetyltransferase+activity+when+bound+to+P%2FCAF%2E&#x0026;journal=Oncogene&#x0026;author=Fuks+F.&#x0026;author=Milner+J.&#x0026;author=Kouzarides+T.&#x0026;publication_year=1998&#x0026;volume=17&#x0026;pages=2531&#x2013;2534" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B10" id="B10"></a>Geng, J., Liu, Y., Guo, Y., Wang, H., Tai, J., Jin, Y., et al. (2019). Correlation between TERT C228T and clinic-pathological features in pediatric papillary thyroid carcinoma. <i>Sci. China Life Sci.</i> 62, 1563&#x2013;1571. doi: 10.1007/s11427-018-9546-5</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31321667" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s11427-018-9546-5" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Correlation+between+TERT+C228T+and+clinic-pathological+features+in+pediatric+papillary+thyroid+carcinoma%2E&#x0026;journal=Sci%2E+China+Life+Sci%2E&#x0026;author=Geng+J.&#x0026;author=Liu+Y.&#x0026;author=Guo+Y.&#x0026;author=Wang+H.&#x0026;author=Tai+J.&#x0026;author=Jin+Y.&#x0026;publication_year=2019&#x0026;volume=62&#x0026;pages=1563&#x2013;1571" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B11" id="B11"></a>Goodman, R. H., and Smolik, S. (2000). CBP/p300 in cell growth, transformation, and development. <i>Genes Dev.</i> 14, 1553&#x2013;1577.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=CBP%2Fp300+in+cell+growth%2C+transformation%2C+and+development%2E&#x0026;journal=Genes+Dev%2E&#x0026;author=Goodman+R.+H.&#x0026;author=Smolik+S.&#x0026;publication_year=2000&#x0026;volume=14&#x0026;pages=1553&#x2013;1577" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B12" id="B12"></a>Healey, C. S., Dunning, A. M., Teare, M. D., Chase, D., Parker, L., Burn, J., et al. (2000). A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. <i>Nat. Genet.</i> 26, 362&#x2013;364. doi: 10.1038/81691</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/11062481" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/81691" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=A+common+variant+in+BRCA2+is+associated+with+both+breast+cancer+risk+and+prenatal+viability%2E&#x0026;journal=Nat%2E+Genet%2E&#x0026;author=Healey+C.+S.&#x0026;author=Dunning+A.+M.&#x0026;author=Teare+M.+D.&#x0026;author=Chase+D.&#x0026;author=Parker+L.&#x0026;author=Burn+J.&#x0026;publication_year=2000&#x0026;volume=26&#x0026;pages=362&#x2013;364" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B13" id="B13"></a>Jagadeesh, K. A., Wenger, A. M., Berger, M. J., Guturu, H., Stenson, P. D., Cooper, D. N., et al. (2016). M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. <i>Nat. Genet.</i> 48, 1581&#x2013;1586. doi: 10.1038/ng.3703</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27776117" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ng.3703" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=M-CAP+eliminates+a+majority+of+variants+of+uncertain+significance+in+clinical+exomes+at+high+sensitivity%2E&#x0026;journal=Nat%2E+Genet%2E&#x0026;author=Jagadeesh+K.+A.&#x0026;author=Wenger+A.+M.&#x0026;author=Berger+M.+J.&#x0026;author=Guturu+H.&#x0026;author=Stenson+P.+D.&#x0026;author=Cooper+D.+N.&#x0026;publication_year=2016&#x0026;volume=48&#x0026;pages=1581&#x2013;1586" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B14" id="B14"></a>Janoueix-Lerosey, I., Schleiermacher, G., and Delattre, O. (2010). Molecular pathogenesis of peripheral neuroblastic tumors. <i>Oncogene</i> 29, 1566&#x2013;1579. doi: 10.1038/onc.2009.518</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20101209" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/onc.2009.518" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Molecular+pathogenesis+of+peripheral+neuroblastic+tumors%2E&#x0026;journal=Oncogene&#x0026;author=Janoueix-Lerosey+I.&#x0026;author=Schleiermacher+G.&#x0026;author=Delattre+O.&#x0026;publication_year=2010&#x0026;volume=29&#x0026;pages=1566&#x2013;1579" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B15" id="B15"></a>Kim, D., Langmead, B., and Salzberg, S. L. (2015). HISAT: a fast spliced aligner with low memory requirements. <i>Nat. Methods</i> 12, 357&#x2013;360. doi: 10.1038/nmeth.3317</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25751142" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nmeth.3317" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=HISAT%3A+a+fast+spliced+aligner+with+low+memory+requirements%2E&#x0026;journal=Nat%2E+Methods&#x0026;author=Kim+D.&#x0026;author=Langmead+B.&#x0026;author=Salzberg+S.+L.&#x0026;publication_year=2015&#x0026;volume=12&#x0026;pages=357&#x2013;360" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B16" id="B16"></a>Knudson, A. G. (1996). Hereditary cancer: two hits revisited. <i>J. Cancer Res. Clin. Oncol.</i> 122, 135&#x2013;140. doi: 10.1007/bf01366952</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/8601560" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/bf01366952" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Hereditary+cancer%3A+two+hits+revisited%2E&#x0026;journal=J%2E+Cancer+Res%2E+Clin%2E+Oncol%2E&#x0026;author=Knudson+A.+G.&#x0026;publication_year=1996&#x0026;volume=122&#x0026;pages=135&#x2013;140" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B17" id="B17"></a>Kwon, W. S., Rha, S. Y., Jeung, H. C., Kim, T. S., and Chung, H. C. (2017). Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines. <i>Biochem. Pharmacol.</i> 138, 163&#x2013;173. doi: 10.1016/j.bcp.2017.04.015</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28431939" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.bcp.2017.04.015" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Modulation+of+HAT+activity+by+the+BRCA2+N372H+variation+is+a+novel+mechanism+of+paclitaxel+resistance+in+breast+cancer+cell+lines%2E&#x0026;journal=Biochem%2E+Pharmacol%2E&#x0026;author=Kwon+W.+S.&#x0026;author=Rha+S.+Y.&#x0026;author=Jeung+H.+C.&#x0026;author=Kim+T.+S.&#x0026;author=Chung+H.+C.&#x0026;publication_year=2017&#x0026;volume=138&#x0026;pages=163&#x2013;173" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B18" id="B18"></a>Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., et al. (2016). Analysis of protein-coding genetic variation in 60,706 humans. <i>Nature</i> 536, 285&#x2013;291.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Analysis+of+protein-coding+genetic+variation+in+60%2C706+humans%2E&#x0026;journal=Nature&#x0026;author=Lek+M.&#x0026;author=Karczewski+K.+J.&#x0026;author=Minikel+E.+V.&#x0026;author=Samocha+K.+E.&#x0026;author=Banks+E.&#x0026;author=Fennell+T.&#x0026;publication_year=2016&#x0026;volume=536&#x0026;pages=285&#x2013;291" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B19" id="B19"></a>Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. <i>Bioinformatics</i> 25, 1754&#x2013;1760. doi: 10.1093/bioinformatics/btp324</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/19451168" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/bioinformatics/btp324" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Fast+and+accurate+short+read+alignment+with+Burrows-Wheeler+transform%2E&#x0026;journal=Bioinformatics&#x0026;author=Li+H.&#x0026;author=Durbin+R.&#x0026;publication_year=2009&#x0026;volume=25&#x0026;pages=1754&#x2013;1760" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B20" id="B20"></a>Li, Z., Zhu, P., Huang, H., Pan, Y., Han, P., Cui, H., et al. (2019). Identification of a novel COL4A5 mutation in the proband initially diagnosed as IgAN from a Chinese family with X-linked Alport syndrome. <i>Sci. China Life Sci.</i> 62, 1572&#x2013;1579. doi: 10.1007/s11427-018-9545-3</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31209800" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s11427-018-9545-3" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Identification+of+a+novel+COL4A5+mutation+in+the+proband+initially+diagnosed+as+IgAN+from+a+Chinese+family+with+X-linked+Alport+syndrome%2E&#x0026;journal=Sci%2E+China+Life+Sci%2E&#x0026;author=Li+Z.&#x0026;author=Zhu+P.&#x0026;author=Huang+H.&#x0026;author=Pan+Y.&#x0026;author=Han+P.&#x0026;author=Cui+H.&#x0026;publication_year=2019&#x0026;volume=62&#x0026;pages=1572&#x2013;1579" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B21" id="B21"></a>Lonergan, G. J., Schwab, C. M., Suarez, E. S., and Carlson, C. L. (2002). Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. <i>Radiographics</i> 22, 911&#x2013;934. doi: 10.1148/radiographics.22.4.g02jl15911</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/12110723" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1148/radiographics.22.4.g02jl15911" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Neuroblastoma%2C+ganglioneuroblastoma%2C+and+ganglioneuroma%3A+radiologic-pathologic+correlation%2E&#x0026;journal=Radiographics&#x0026;author=Lonergan+G.+J.&#x0026;author=Schwab+C.+M.&#x0026;author=Suarez+E.+S.&#x0026;author=Carlson+C.+L.&#x0026;publication_year=2002&#x0026;volume=22&#x0026;pages=911&#x2013;934" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B22" id="B22"></a>Love, M. I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. <i>Genome Biol.</i> 15:550.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Moderated+estimation+of+fold+change+and+dispersion+for+RNA-seq+data+with+DESeq2%2E&#x0026;journal=Genome+Biol%2E&#x0026;author=Love+M.+I.&#x0026;author=Huber+W.&#x0026;author=Anders+S.&#x0026;publication_year=2014&#x0026;volume=15&#x0026;issue=550" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B23" id="B23"></a>Luksch, R., Castellani, M. R., Collini, P., De Bernardi, B., Conte, M., Gambini, C., et al. (2016). Neuroblastoma (Peripheral neuroblastic tumours). <i>Crit. Rev. Oncol. Hematol.</i> 107, 163&#x2013;181.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Neuroblastoma+%28Peripheral+neuroblastic+tumours%29%2E&#x0026;journal=Crit%2E+Rev%2E+Oncol%2E+Hematol%2E&#x0026;author=Luksch+R.&#x0026;author=Castellani+M.+R.&#x0026;author=Collini+P.&#x0026;author=De+Bernardi+B.&#x0026;author=Conte+M.&#x0026;author=Gambini+C.&#x0026;publication_year=2016&#x0026;volume=107&#x0026;pages=163&#x2013;181" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B24" id="B24"></a>McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., et al. (2010). The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. <i>Genome Res.</i> 20, 1297&#x2013;1303. doi: 10.1101/gr.107524.110</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20644199" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1101/gr.107524.110" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=The+genome+analysis+toolkit%3A+a+MapReduce+framework+for+analyzing+next-generation+DNA+sequencing+data%2E&#x0026;journal=Genome+Res%2E&#x0026;author=McKenna+A.&#x0026;author=Hanna+M.&#x0026;author=Banks+E.&#x0026;author=Sivachenko+A.&#x0026;author=Cibulskis+K.&#x0026;author=Kernytsky+A.&#x0026;publication_year=2010&#x0026;volume=20&#x0026;pages=1297&#x2013;1303" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B25" id="B25"></a>Mosse, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., et al. (2008). Identification of ALK as a major familial neuroblastoma predisposition gene. <i>Nature</i> 455, 930&#x2013;935. doi: 10.1038/nature07261</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/18724359" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature07261" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Identification+of+ALK+as+a+major+familial+neuroblastoma+predisposition+gene%2E&#x0026;journal=Nature&#x0026;author=Mosse+Y.+P.&#x0026;author=Laudenslager+M.&#x0026;author=Longo+L.&#x0026;author=Cole+K.+A.&#x0026;author=Wood+A.&#x0026;author=Attiyeh+E.+F.&#x0026;publication_year=2008&#x0026;volume=455&#x0026;pages=930&#x2013;935" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B26" id="B26"></a>Pertea, M., Pertea, G. M., Antonescu, C. M., Chang, T. C., Mendell, J. T., and Salzberg, S. L. (2015). StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. <i>Nat. Biotechnol.</i> 33, 290&#x2013;295. doi: 10.1038/nbt.3122</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25690850" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nbt.3122" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=StringTie+enables+improved+reconstruction+of+a+transcriptome+from+RNA-seq+reads%2E&#x0026;journal=Nat%2E+Biotechnol%2E&#x0026;author=Pertea+M.&#x0026;author=Pertea+G.+M.&#x0026;author=Antonescu+C.+M.&#x0026;author=Chang+T.+C.&#x0026;author=Mendell+J.+T.&#x0026;author=Salzberg+S.+L.&#x0026;publication_year=2015&#x0026;volume=33&#x0026;pages=290&#x2013;295" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B27" id="B27"></a>Ramus, S. J., Vierkant, R. A., Johnatty, S. E., Pike, M. C., Van Den Berg, D. J., Wu, A. H., et al. (2008). Consortium analysis of 7 candidate SNPs for ovarian cancer. <i>Int. J. Cancer.</i> 123, 380&#x2013;388.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Consortium+analysis+of+7+candidate+SNPs+for+ovarian+cancer%2E&#x0026;journal=Int%2E+J%2E+Cancer%2E&#x0026;author=Ramus+S.+J.&#x0026;author=Vierkant+R.+A.&#x0026;author=Johnatty+S.+E.&#x0026;author=Pike+M.+C.&#x0026;author=Van+Den+Berg+D.+J.&#x0026;author=Wu+A.+H.&#x0026;publication_year=2008&#x0026;volume=123&#x0026;pages=380&#x2013;388" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B28" id="B28"></a>Ritenour, L. E., Randall, M. P., Bosse, K. R., and Diskin, S. J. (2018). Genetic susceptibility to neuroblastoma: current knowledge and future directions. <i>Cell Tissue Res.</i> 372, 287&#x2013;307. doi: 10.1007/s00441-018-2820-3</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29589100" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00441-018-2820-3" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Genetic+susceptibility+to+neuroblastoma%3A+current+knowledge+and+future+directions%2E&#x0026;journal=Cell+Tissue+Res%2E&#x0026;author=Ritenour+L.+E.&#x0026;author=Randall+M.+P.&#x0026;author=Bosse+K.+R.&#x0026;author=Diskin+S.+J.&#x0026;publication_year=2018&#x0026;volume=372&#x0026;pages=287&#x2013;307" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B29" id="B29"></a>Rousset-Jablonski, C., and Gompel, A. (2017). Screening for familial cancer risk: focus on breast cancer. <i>Maturitas</i> 105, 69&#x2013;77. doi: 10.1016/j.maturitas.2017.08.004</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28818315" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.maturitas.2017.08.004" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Screening+for+familial+cancer+risk%3A+focus+on+breast+cancer%2E&#x0026;journal=Maturitas&#x0026;author=Rousset-Jablonski+C.&#x0026;author=Gompel+A.&#x0026;publication_year=2017&#x0026;volume=105&#x0026;pages=69&#x2013;77" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B30" id="B30"></a>Rudd, M. F., Sellick, G. S., Webb, E. L., Catovsky, D., and Houlston, R. S. (2006). Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. <i>Blood</i> 108, 638&#x2013;644. doi: 10.1182/blood-2005-12-5022</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/16574953" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1182/blood-2005-12-5022" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Variants+in+the+ATM-BRCA2-CHEK2+axis+predispose+to+chronic+lymphocytic+leukemia%2E&#x0026;journal=Blood&#x0026;author=Rudd+M.+F.&#x0026;author=Sellick+G.+S.&#x0026;author=Webb+E.+L.&#x0026;author=Catovsky+D.&#x0026;author=Houlston+R.+S.&#x0026;publication_year=2006&#x0026;volume=108&#x0026;pages=638&#x2013;644" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B31" id="B31"></a>Schwarz, J. M., Cooper, D. N., Schuelke, M., and Seelow, D. (2014). MutationTaster2: mutation prediction for the deep-sequencing age. <i>Nat. Methods</i> 11, 361&#x2013;362. doi: 10.1038/nmeth.2890</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24681721" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nmeth.2890" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=MutationTaster2%3A+mutation+prediction+for+the+deep-sequencing+age%2E&#x0026;journal=Nat%2E+Methods&#x0026;author=Schwarz+J.+M.&#x0026;author=Cooper+D.+N.&#x0026;author=Schuelke+M.&#x0026;author=Seelow+D.&#x0026;publication_year=2014&#x0026;volume=11&#x0026;pages=361&#x2013;362" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B32" id="B32"></a>Trochet, D., Bourdeaut, F., Janoueix-Lerosey, I., Deville, A., de Pontual, L., Schleiermacher, G., et al. (2004). Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. <i>Am. J. Hum. Genet.</i> 74, 761&#x2013;764. doi: 10.1086/383253</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/15024693" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1086/383253" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Germline+mutations+of+the+paired-like+homeobox+2B+%28PHOX2B%29+gene+in+neuroblastoma%2E&#x0026;journal=Am%2E+J%2E+Hum%2E+Genet%2E&#x0026;author=Trochet+D.&#x0026;author=Bourdeaut+F.&#x0026;author=Janoueix-Lerosey+I.&#x0026;author=Deville+A.&#x0026;author=de+Pontual+L.&#x0026;author=Schleiermacher+G.&#x0026;publication_year=2004&#x0026;volume=74&#x0026;pages=761&#x2013;764" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B33" id="B33"></a>Valencia, O. M., Samuel, S. E., Viscusi, R. K., Riall, T. S., and Neumayer, L. A. (2017). The role of genetic testing in patients with breast cancer: a review. <i>JAMA Surg.</i> 152, 589&#x2013;594. doi: 10.1001/jamasurg.2017.0552</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28423155" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1001/jamasurg.2017.0552" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=The+role+of+genetic+testing+in+patients+with+breast+cancer%3A+a+review%2E&#x0026;journal=JAMA+Surg%2E&#x0026;author=Valencia+O.+M.&#x0026;author=Samuel+S.+E.&#x0026;author=Viscusi+R.+K.&#x0026;author=Riall+T.+S.&#x0026;author=Neumayer+L.+A.&#x0026;publication_year=2017&#x0026;volume=152&#x0026;pages=589&#x2013;594" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B34" id="B34"></a>Wang, K., Li, M., and Hakonarson, H. (2010). ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. <i>Nucleic Acids Res.</i> 38:e164. doi: 10.1093/nar/gkq603</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20601685" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gkq603" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=ANNOVAR%3A+functional+annotation+of+genetic+variants+from+high-throughput+sequencing+data%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Wang+K.&#x0026;author=Li+M.&#x0026;author=Hakonarson+H.&#x0026;publication_year=2010&#x0026;volume=38&#x0026;issue=e164" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B35" id="B35"></a>Wenham, R. M., Schildkraut, J. M., McLean, K., Calingaert, B., Bentley, R. C., Marks, J., et al. (2003). Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer. <i>Clin. Cancer Res.</i> 9, 4396&#x2013;4403.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Polymorphisms+in+BRCA1+and+BRCA2+and+risk+of+epithelial+ovarian+cancer%2E&#x0026;journal=Clin%2E+Cancer+Res%2E&#x0026;author=Wenham+R.+M.&#x0026;author=Schildkraut+J.+M.&#x0026;author=McLean+K.&#x0026;author=Calingaert+B.&#x0026;author=Bentley+R.+C.&#x0026;author=Marks+J.&#x0026;publication_year=2003&#x0026;volume=9&#x0026;pages=4396&#x2013;4403" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B36" id="B36"></a>Yang, Y., Liu, Z., Wang, F., Temviriyanukul, P., Ma, X., Tu, Y., et al. (2015). FANCD2 and REV1 cooperate in the protection of nascent DNA strands in response to replication stress. <i>Nucleic Acids Res.</i> 43, 8325&#x2013;8339. doi: 10.1093/nar/gkv737</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26187992" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gkv737" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=FANCD2+and+REV1+cooperate+in+the+protection+of+nascent+DNA+strands+in+response+to+replication+stress%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Yang+Y.&#x0026;author=Liu+Z.&#x0026;author=Wang+F.&#x0026;author=Temviriyanukul+P.&#x0026;author=Ma+X.&#x0026;author=Tu+Y.&#x0026;publication_year=2015&#x0026;volume=43&#x0026;pages=8325&#x2013;8339" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B37" id="B37"></a>Yu, G., Wang, L. G., Han, Y., and He, Q. Y. (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. <i>OMICS</i> 16, 284&#x2013;287. doi: 10.1089/omi.2011.0118</p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22455463" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1089/omi.2011.0118" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?&#x0026;title=clusterProfiler%3A+an+R+package+for+comparing+biological+themes+among+gene+clusters%2E&#x0026;journal=OMICS&#x0026;author=Yu+G.&#x0026;author=Wang+L.+G.&#x0026;author=Han+Y.&#x0026;author=He+Q.+Y.&#x0026;publication_year=2012&#x0026;volume=16&#x0026;pages=284&#x2013;287" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="B38" id="B38"></a>Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., et al. (2015). Germline mutations in predisposition genes in pediatric cancer. <i>N. Engl. J. Med.</i> 373, 2336&#x2013;2346.</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?&#x0026;title=Germline+mutations+in+predisposition+genes+in+pediatric+cancer%2E&#x0026;journal=N%2E+Engl%2E+J%2E+Med%2E&#x0026;author=Zhang+J.&#x0026;author=Walsh+M.+F.&#x0026;author=Wu+G.&#x0026;author=Edmonson+M.+N.&#x0026;author=Gruber+T.+A.&#x0026;author=Easton+J.&#x0026;publication_year=2015&#x0026;volume=373&#x0026;pages=2336&#x2013;2346" target="_blank">Google Scholar</a></p>
</div>
</div>
<div class="thinLineM20"></div>
<div class="AbstractSummary">
<p><span>Keywords</span>: peripheral neuroblastic tumors, neuroblastoma, ganglioneuroma, whole-genome sequencing, RNA-Seq, <i>BRCA2</i>, cancer predisposition gene</p>
<p><span>Citation:</span> Yang Y, Chen J, Qin H, Jin Y, Zhang L, Yang S, Wang H, Fu L, Hong E, Yu Y, Lu J, Chang Y, Ni X, Xu M, Shi T and Guo Y (2021) A Novel Germline Compound Heterozygous Mutation of <i>BRCA2</i> Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings. <i>Front. Genet.</i> 12:652718. doi: 10.3389/fgene.2021.652718</p>
<p id="timestamps">
<span>Received:</span> 13 January 2021; <span>Accepted:</span> 31 May 2021;<br><span>Published:</span> 23 July 2021.</p>
<div>
<p>Edited by:</p>
<a href="https://loop.frontiersin.org/people/1353308/overview">Nadeem Abbas</a>, Riphah International University, Pakistan</div>
<div>
<p>Reviewed by:</p>
<a href="https://loop.frontiersin.org/people/792280/overview">Yifan Zhang</a>, University of Arkansas at Little Rock, United States<br>
<a href="https://loop.frontiersin.org/people/661168/overview">Ting Li</a>, University of Arkansas at Little Rock, United States</div>
<p><span>Copyright</span> &#x00A9; 2021 Yang, Chen, Qin, Jin, Zhang, Yang, Wang, Fu, Hong, Yu, Lu, Chang, Ni, Xu, Shi and Guo. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<p><span>*Correspondence:</span> Min Xu, <a id="encmail">amFja3htMTIzNkAxMjYuY29t</a>; Tieliu Shi, <a id="encmail">dGllbGl1c2hpQHlhaG9vLmNvbQ==</a>; <a id="encmail">dGxzaGlAYmlvLmVjbnUuZWR1LmNu</a>; Yongli Guo, <a id="encmail">Z3VveW9uZ2xpQGJjaC5jb20uY24=</a>; <a id="encmail">amFja3htMTIzNkAxMjYuY29t</a></p>
<p><sup>&#x2020;</sup>These authors have contributed equally to this work</p>
<div class="clear"></div>
</div></div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fgene.2021.652718" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">3K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">1,3K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">1</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/652718#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fgene.2021.652718" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fgene.2021.652718" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/1353308/overview" data-event="editorInfo-a-drNadeemAbbas" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">D</span><span class="notranslate">N</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Dr. Nadeem  Abbas</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Riphah International University, Faisalabad Campus, Pakistan</div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/661168/overview" data-event="editorInfo-a-tingLi" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">T</span><span class="notranslate">L</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Ting  Li</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">University of Arkansas at Little Rock, United States</div></div></a><a href="https://loop.frontiersin.org/people/792280/overview" data-event="editorInfo-a-yifanZhang" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">Y</span><span class="notranslate">Z</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Yifan  Zhang</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">National Center for Toxicological Research (FDA), United States</div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal">
<li><a href="#h1">Abstract</a></li>
<li><a href="#h2">Introduction</a></li>
<li><a href="#h3">Materials and Methods</a></li>
<li><a href="#h4">Results</a></li>
<li><a href="#h5">Discussion</a></li>
<li><a href="#h6">Conclusion</a></li>
<li><a href="#h7">Limitations</a></li>
<li><a href="#h8">Data Availability Statement</a></li>
<li><a href="#h9">Ethics Statement</a></li>
<li><a href="#S9">Author Contributions</a></li>
<li><a href="#fun1">Funding</a></li>
<li><a href="#conf1">Conflict of Interest</a></li>
<li><a href="#h13">Publisher&#x2019;s Note</a></li>
<li><a href="#ack1">Acknowledgments</a></li>
<li><a href="#S12">Supplementary Material</a></li>
<li><a href="#refer1">References</a></li>
</ul>
</div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fgene.2021.652718" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media SA. All rights reserved.</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/genetics/articles/10.3389/fgene.2021.652718/full",["Reactive",16],{"main":17,"user":514,"article":515,"articleHub":921,"mainHeader":925},{"ibar":18,"footer":276,"newsletterComponent":-1,"snackbarItem":358,"toggleShowSnackbar":359,"contentfulJournal":360,"graphJournal":414,"settingsFeaturesSwitchers":418,"templateToggleBanner":419,"tenantConfig":479},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":207,"aboutJournal":208,"mainLinks":257,"journalLinks":264,"helpCenterLink":273},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIR Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=1&fieldid=30&specialtyid=0&entitytype=2&entityid=240",{"id":115,"name":116,"slug":117,"sections":118},240,"Frontiers in Genetics","genetics",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203],{"id":120,"name":121,"slug":122},549,"Applied Genetic Epidemiology","applied-genetic-epidemiology",{"id":124,"name":125,"slug":126},536,"Behavioral and Psychiatric Genetics","behavioral-and-psychiatric-genetics",{"id":128,"name":129,"slug":130},2030,"Cancer Genetics and Oncogenomics","cancer-genetics-and-oncogenomics",{"id":132,"name":133,"slug":134},551,"Computational Genomics","computational-genomics",{"id":136,"name":137,"slug":138},2512,"Cytogenomics","cytogenomics",{"id":140,"name":141,"slug":142},650,"ELSI in Science and Genetics","elsi-in-science-and-genetics",{"id":144,"name":145,"slug":146},455,"Epigenomics and Epigenetics","epigenomics-and-epigenetics",{"id":148,"name":149,"slug":150},535,"Evolutionary and Population Genetics","evolutionary-and-population-genetics",{"id":152,"name":153,"slug":154},596,"Genetics of Aging","genetics-of-aging",{"id":156,"name":157,"slug":158},635,"Genetics of Common and Rare Diseases","genetics-of-common-and-rare-diseases",{"id":160,"name":161,"slug":162},557,"Genomic Assay Technology","genomic-assay-technology",{"id":164,"name":165,"slug":166},1520,"Genomics of Plants and the Phytoecosystem","genomics-of-plants-and-the-phytoecosystem",{"id":168,"name":169,"slug":170},1419,"Human and Medical Genomics","human-and-medical-genomics",{"id":172,"name":173,"slug":174},2237,"Immunogenetics","immunogenetics",{"id":176,"name":177,"slug":178},241,"Livestock Genomics","livestock-genomics",{"id":180,"name":181,"slug":182},19,"Neurogenomics","neurogenomics",{"id":184,"name":185,"slug":186},3423,"Nutritional Genomics","nutritional-genomics",{"id":188,"name":189,"slug":190},198,"Pharmacogenetics and Pharmacogenomics","pharmacogenetics-and-pharmacogenomics",{"id":192,"name":193,"slug":194},556,"Predictive Toxicology and Exposomics","predictive-toxicology-and-exposomics",{"id":196,"name":197,"slug":198},555,"RNA","rna",{"id":200,"name":201,"slug":202},454,"Statistical Genetics and Methodology","statistical-genetics-and-methodology",{"id":204,"name":205,"slug":206},685,"Stem Cell Research","stem-cell-research","Sections",[209,233],{"title":210,"links":211},"Scope",[212,215,218,221,224,227,230],{"text":213,"url":214,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/genetics/about#about-editors",{"text":216,"url":217,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/genetics/about#about-scope",{"text":219,"url":220,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/genetics/about#about-facts",{"text":222,"url":223,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/genetics/about#about-submission",{"text":225,"url":226,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/genetics/about#about-open",{"text":228,"url":229,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/genetics/about#copyright-statement",{"text":231,"url":232,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/genetics/about#about-quality",{"title":234,"links":235},"For authors",[236,239,242,245,248,251,254],{"text":237,"url":238,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/genetics/for-authors/why-submit",{"text":240,"url":241,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/genetics/for-authors/article-types",{"text":243,"url":244,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/genetics/for-authors/author-guidelines",{"text":246,"url":247,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/genetics/for-authors/editor-guidelines",{"text":249,"url":250,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/genetics/for-authors/publishing-fees",{"text":252,"url":253,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/genetics/for-authors/submission-checklist",{"text":255,"url":256,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/genetics/for-authors/contact-editorial-office",[258,261],{"text":259,"url":260,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":262,"url":263,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[265,268,270],{"text":266,"url":267,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":269,"target":27,"ariaLabel":28},"research-topics",{"text":271,"url":272,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":274,"url":275,"target":77,"ariaLabel":274},"Help center","https://helpcenter.frontiersin.org",{"blocks":277,"socialLinks":331,"copyright":355,"termsAndConditionsUrl":356,"privacyPolicyUrl":357},[278,292,302,316],{"title":279,"links":280},"Guidelines",[281,283,286,289,291],{"text":243,"url":282,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":284,"url":285,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":287,"url":288,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":246,"url":290,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":293,"links":294},"Explore",[295,296,299,301],{"text":266,"url":263,"target":27,"ariaLabel":28},{"text":297,"url":298,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":300,"url":260,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":303,"links":304},"Outreach",[305,308,311,315],{"text":306,"url":92,"target":77,"ariaLabel":307},"Frontiers Forum ","Frontiers Forum website",{"text":309,"url":310,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":312,"url":313,"target":77,"ariaLabel":314},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":317,"links":318},"Connect",[319,320,324,327,330],{"text":274,"url":275,"target":77,"ariaLabel":274},{"text":321,"url":322,"target":77,"ariaLabel":323},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":325,"url":111,"target":27,"ariaLabel":326},"Contact us ","Subscribe to newsletter",{"text":328,"url":329,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[332,340,345,350],{"link":333,"type":336,"color":337,"icon":338,"size":339,"hiddenText":13},{"text":334,"url":335,"target":77,"ariaLabel":334},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":341,"type":336,"color":337,"icon":344,"size":339,"hiddenText":13},{"text":342,"url":343,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":346,"type":336,"color":337,"icon":349,"size":339,"hiddenText":13},{"text":347,"url":348,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":351,"type":336,"color":337,"icon":354,"size":339,"hiddenText":13},{"text":352,"url":353,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media SA. All rights reserved.","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":361,"identifier":115,"name":116,"slug":117,"banner":362,"description":407,"mission":408,"palette":409,"impactFactor":410,"citeScore":411,"citations":412,"showTagline":28,"twitter":413},"Journal",[363],{"id":364,"src":365,"name":366,"type":367,"width":368,"height":369,"idHash":370,"archive":371,"brandId":372,"limited":371,"fileSize":373,"isPublic":374,"original":375,"copyright":19,"extension":376,"thumbnails":378,"dateCreated":386,"description":19,"orientation":387,"userCreated":388,"watermarked":371,"dateModified":386,"datePublished":389,"ecsArchiveFiles":390,"propertyOptions":391,"property_Channel":396,"property_Sub-Type":398,"property_Asset_Type":400,"activeOriginalFocusPoint":402,"property_Office_Department":405},"12AFEC62-10F2-4A9B-900C8422E4B53D54","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/webimage-A09D2065-D257-435D-987C43E79D7FBDFD.png","FGENE_Main Visual_Purple_Website","image",6016,4016,"3b54103c3aad636f",0,"22C10171-81B3-4DA6-99342F272A32E8BB",10275124,1,"https://brand.frontiersin.org/m/3b54103c3aad636f/original/FGENE_Main-Visual_Purple_Website.jpg",[377],"jpg",{"mini":379,"thul":380,"webimage":365,"Guidelines":381,"WebsiteJpg_XL":382,"WebsiteWebP_L":383,"WebsiteWebP_M":384,"WebsiteWebP_XL":385},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/mini-8741E412-02C1-4126-84DDA81B97389D5E.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/thul-D176A038-2FDA-438D-B9A7E98CF3926BBE.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/Guidelines-FGENE_Main Visual_Purple_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteJpg_XL-FGENE_Main Visual_Purple_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteWebP_L-FGENE_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteWebP_M-FGENE_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/12AFEC62-10F2-4A9B-900C8422E4B53D54/511D4207-6085-4D24-9E5E56EBCA9EBCD2/WebsiteWebP_XL-FGENE_Main Visual_Purple_Website.webp","2022-06-27T09:59:48Z","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[392,393,394,395],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[397],"frontiersin_org",[399],"Main_Visual",[401],"Photography",{"x":403,"y":404},3008,2008,[406],"Publishing","Explore research from the world's most cited genetics and heredity journal, advancing our understanding of genes from humans to plants and other model organisms.","\u003Cp>Frontiers in Genetics publishes research on genes and genomes relating to all the domains of life, from humans to livestock, and plants to other model organisms.\u003C/p>\n\n\u003Cp>Led by Field Chief Editor Enrico Domenici (Department of Cellular, Computational and Integrated Biology, University of Trento, Italy) Frontiers in Genetics is indexed in PubMed Central (PMC) and Scopus, among others, and explores the full spectrum of genetic and genomic research, encompassing fundamental studies and their clinical applications, while also embracing methodological advancements and exploring their applications and implications. Topics of interest include, but are not limited to:\u003C/p>\n\n\u003Cdiv> &bull; how genes or genomes relate to traits and humanpathophysiology\u003C/div>\n\u003Cdiv> &bull; advances in genomic data technology and analysis\u003C/div>\n\u003Cdiv> &bull; gene flow among species and populations\u003C/div>\n\u003Cdiv> &bull; livestock genome research Interactions between organisms, theirenvironment, and xenobiotics\u003C/div>\n\u003Cdiv> &bull; molecular and cellular genetics\u003C/div>\n\u003Cdiv> &bull; societal implicationsof genetic research.\u003C/div>\n\u003Cbr>\n\u003Cp>Submissions that emphasize advancement in the understanding of the function and variability of the genome, the use of genetic and genomic tools, and the analysis of the genetic underpinnings of biological processes are of particular interest to this journal.\u003Cp>\n\u003Cp>Furthermore, the journal actively welcomes submissions which support and advance the UNs Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being.\u003C/p>\n\u003Cp>Manuscripts that focus solely on clinical outcomes, patient management, or therapeutic interventions without a clear genetic or genomic component are not suitable for publication in this journal. Studies that are purely epidemiological or observational, without a foundation in genetic or genomic mechanisms, are also not within the scope of this journal. Manuscripts consisting solely of bioinformatics, computational analyses of public data which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo) or are not highly innovative are not suitable for publication in this journal. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a>, for more information.\u003C/p>\n\u003Cp>Frontiers in Genetics is committed to advancing developments in the field of genetics and genomics by allowing unrestricted access to articles, and communicating scientific knowledge to both researchers and the public, to enable the scientific breakthroughs of the future.\u003C/p>","purple","3.7","5.2","277710","@FrontGenetics",{"id":115,"name":116,"slug":117,"abbreviation":415,"isOnline":13,"isOpenForSubmissions":13,"citeScore":416,"impactFactor":417},"fgene",6.2,2.8,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":359},{"isPublic":13,"allowCompanyUsers":359,"whiteListEmails":420,"enableAllJournals":13,"whiteListJournals":442},[421,422,423,424,425,426,427,428,429,426,430,431,432,433,434,435,436,437,438,439,440,441],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[443,444,445,446,447,448,374,449,450,451,452,453,454,455,456,457,458,459,460,461,462,463,464,465,466,467,468,469,470,471,472,473,474,475,476,477,478],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,141,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":374,"name":374,"availableJournalPages":480,"announcement":484},[267,272,269,481,482,483],"volumes","about","community-reviewers",{"__typename":485,"sys":486,"preHeader":42,"title":488,"description":489,"image":490,"link":512},"Announcement",{"id":487},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[491],{"archive":371,"brandId":372,"copyright":28,"dateCreated":492,"dateModified":493,"datePublished":494,"description":28,"extension":495,"fileSize":497,"height":498,"id":499,"isPublic":371,"limited":371,"name":500,"orientation":387,"original":28,"thumbnails":501,"type":367,"watermarked":371,"width":508,"videoPreviewURLs":509,"tags":510,"textMetaproperties":511,"src":502},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[496],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":502,"thul":503,"mini":504,"WebsiteWebP_L":505,"WebsiteWebP_M":506,"Guidelines":507},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":513,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":516,"isPreviewPage":359,"hasSupplementalData":359,"showCrossmarkWidget":13,"articleTemplate":740,"currentArticlePageMetaInfo":741,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":517,"doi":518,"title":519,"acceptanceDate":520,"receptionDate":521,"publicationDate":522,"lastModifiedDate":523,"isPublished":13,"abstract":524,"researchTopic":525,"articleType":531,"stage":534,"keywords":536,"authors":544,"editors":670,"reviewers":680,"journal":696,"section":703,"impactMetrics":705,"volume":708,"articleVolume":709,"relatedArticles":710,"isPublishedV2":359,"contents":711,"files":715},652718,"10.3389/fgene.2021.652718","A Novel Germline Compound Heterozygous Mutation of BRCA2 Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings",["Date","2021-05-31T09:37:35.000Z"],["Date","2021-01-13T01:42:56.000Z"],["Date","2021-07-23T00:00:00.000Z"],["Date","2025-11-25T04:36:00.912Z"],"Objectives To investigate the genetic variants that are responsible for peripheral neuroblastic tumors (PNTs) oncogenesis in one family case. Methods One family was recruited, including the healthy parents, sister affected by neuroblastoma (NB) and brother suffered from ganglioneuroma (GN). Whole-genome sequencing (WGS) of germline DNA from all the family members and RNA-seq of tumor RNA from the siblings were performed. Mutants were validated by Sanger sequencing and co-IP was performed to assess the impact of mutant on chemosensitivity in SH-SY5Y cell line. Results A novel compound heterozygous mutation of BRCA2 was locked as the cause of carcinogenesis. One allele was BRCA2-S871X (stop-gain) from the siblings mother, the other was BRCA2-N372H (missense) from their father. This novel compound heterozygous mutations of BRCA2 gene associated with PNTs by disordering DNA damage and response (DDR) signal pathway. Moreover, chemosensitivity was reduced in NB cell line due to BRCA2-N372H mutant. Conclusions In summary, these results revealed a novel germline compound heterozygous mutation of BRCA2 gene associated with familial PNTs.",{"id":526,"title":527,"articlesCount":528,"isMagazinePage":13,"slug":529,"isOpenForSubmission":359,"views":530},15957,"Emerging Technologies Powering Rare and Neglected Disease Diagnosis and Therapy Development",21,"emerging-technologies-powering-rare-and-neglected-disease-diagnosis-and-therapy-development",101371,{"id":532,"name":533},24,"Original Research",{"id":535,"name":19},18,[537,538,539,540,541,542,543],"peripheral neuroblastic tumors","Neuroblastoma","Ganglioneuroma","Whole- genome sequencing","RNA-Seq","BRCA2","Cancer predisposition gene",[545,558,566,573,582,588,594,600,607,613,621,630,638,647,654,661],{"id":546,"firstName":547,"middleName":19,"lastName":548,"givenNames":549,"isCorresponding":359,"isProfilePublic":13,"userId":546,"email":-1,"affiliations":550},963139,"Yeran","Yang","Yeran ",[551,554,556],{"organizationName":552,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},"Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University","China",{"organizationName":555,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},"Biobank for Clinical Data and Samples in Pediatric, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University",{"organizationName":557,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},"Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University",{"id":559,"firstName":560,"middleName":19,"lastName":561,"givenNames":562,"isCorresponding":359,"isProfilePublic":13,"userId":559,"email":-1,"affiliations":563},821216,"Jiwei","Chen","Jiwei ",[564],{"organizationName":565,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},"Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University",{"id":371,"firstName":567,"middleName":19,"lastName":568,"givenNames":569,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":570},"Hong","Qin","Hong ",[571],{"organizationName":572,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},"Department of Surgical Oncology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University",{"id":574,"firstName":575,"middleName":19,"lastName":576,"givenNames":577,"isCorresponding":359,"isProfilePublic":13,"userId":574,"email":-1,"affiliations":578},600699,"Yaqiong","Jin","Yaqiong ",[579,580,581],{"organizationName":552,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":555,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":557,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":371,"firstName":583,"middleName":19,"lastName":584,"givenNames":585,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":586},"Li","Zhang","Li ",[587],{"organizationName":565,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":589,"firstName":590,"middleName":19,"lastName":548,"givenNames":591,"isCorresponding":359,"isProfilePublic":13,"userId":589,"email":-1,"affiliations":592},599994,"Shen","Shen ",[593],{"organizationName":572,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":371,"firstName":595,"middleName":19,"lastName":596,"givenNames":597,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":598},"Huanmin","Wang","Huanmin ",[599],{"organizationName":572,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":371,"firstName":601,"middleName":19,"lastName":602,"givenNames":603,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":604},"Libing","Fu","Libing ",[605],{"organizationName":606,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},"Department of Pathology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University",{"id":371,"firstName":608,"middleName":19,"lastName":567,"givenNames":609,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":610},"Enyu","Enyu ",[611,612],{"organizationName":552,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":555,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":371,"firstName":614,"middleName":19,"lastName":615,"givenNames":616,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":617},"Yongbo","Yu","Yongbo ",[618,619,620],{"organizationName":552,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":555,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":557,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":622,"firstName":623,"middleName":19,"lastName":624,"givenNames":625,"isCorresponding":359,"isProfilePublic":13,"userId":622,"email":-1,"affiliations":626},1371032,"Jie","Lu","Jie ",[627,628,629],{"organizationName":552,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":555,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":557,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":371,"firstName":631,"middleName":19,"lastName":632,"givenNames":633,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":634},"Yan","Chang","Yan ",[635,636,637],{"organizationName":552,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":555,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":557,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":639,"firstName":640,"middleName":19,"lastName":641,"givenNames":642,"isCorresponding":359,"isProfilePublic":13,"userId":639,"email":-1,"affiliations":643},925887,"Xin","Ni","Xin ",[644,645,646],{"organizationName":552,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":555,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":557,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":371,"firstName":648,"middleName":19,"lastName":649,"givenNames":650,"isCorresponding":359,"isProfilePublic":359,"userId":371,"email":-1,"affiliations":651},"Min","Xu","Min ",[652],{"organizationName":653,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},"Department of Surgery, Shanghai Childrens Medical Center, School of Medicine, Shanghai Jiao Tong University",{"id":655,"firstName":656,"middleName":19,"lastName":657,"givenNames":658,"isCorresponding":359,"isProfilePublic":13,"userId":655,"email":-1,"affiliations":659},557812,"Tieliu","Shi","Tieliu ",[660],{"organizationName":565,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"id":662,"firstName":663,"middleName":19,"lastName":664,"givenNames":665,"isCorresponding":359,"isProfilePublic":13,"userId":662,"email":-1,"affiliations":666},1155881,"Yongli","Guo","Yongli ",[667,668,669],{"organizationName":552,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":555,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":557,"countryName":553,"cityName":19,"stateName":19,"zipCode":19},[671],{"id":672,"firstName":673,"middleName":19,"lastName":674,"givenNames":675,"isCorresponding":359,"isProfilePublic":13,"userId":672,"email":-1,"affiliations":676},1353308,"Dr. Nadeem","Abbas","Dr. Nadeem ",[677],{"organizationName":678,"countryName":679,"cityName":19,"stateName":19,"zipCode":19},"Riphah International University, Faisalabad Campus","Pakistan",[681,689],{"id":682,"firstName":683,"middleName":19,"lastName":583,"givenNames":684,"isCorresponding":359,"isProfilePublic":13,"userId":682,"email":-1,"affiliations":685},661168,"Ting","Ting ",[686],{"organizationName":687,"countryName":688,"cityName":19,"stateName":19,"zipCode":19},"University of Arkansas at Little Rock","United States",{"id":690,"firstName":691,"middleName":19,"lastName":584,"givenNames":692,"isCorresponding":359,"isProfilePublic":13,"userId":690,"email":-1,"affiliations":693},792280,"Yifan","Yifan ",[694],{"organizationName":695,"countryName":688,"cityName":19,"stateName":19,"zipCode":19},"National Center for Toxicological Research (FDA)",{"id":115,"slug":117,"name":116,"shortName":697,"electronicISSN":698,"field":699,"specialtyId":28,"journalSectionPaths":701},"Front. Genet.","1664-8021",{"id":700,"domainId":374},30,[702],{"section":703},{"id":156,"name":157,"slug":158,"specialtyId":704},1412,{"views":706,"downloads":707,"citations":374},2982,1260,12,"Volume 12 - 2021",[],{"titleHtml":712,"fullTextHtml":713,"menuHtml":714},"A Novel Germline Compound Heterozygous Mutation of \u003Ci>BRCA2\u003C/i> Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings","\u003Cdiv class=\"JournalAbstract\">\r\n\u003Ca id=\"h1\" name=\"h1\">\u003C/a>\r\n\u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\r\n\u003Ca href=\"https://loop.frontiersin.org/people/963139\" class=\"user-id-963139\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/963139/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"\r\nYeran Yang,,&#x;\">Yeran Yang\u003C/a>\u003Csup>1,2,3&#x2020;\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/821216\" class=\"user-id-821216\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/821216/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Jiwei Chen&#x;\">Jiwei Chen\u003C/a>\u003Csup>4&#x2020;\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Hong Qin&#x;\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Hong Qin\u003Csup>5&#x2020;\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/600699\" class=\"user-id-600699\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/600699/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Yaqiong Jin,,\">Yaqiong Jin\u003C/a>\u003Csup>1,2,3\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Li Zhang\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Li Zhang\u003Csup>4\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/599994\" class=\"user-id-599994\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/599994/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Shen Yang\">Shen Yang\u003C/a>\u003Csup>5\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Huanmin Wang\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Huanmin Wang\u003Csup>5\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Libing Fu\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Libing Fu\u003Csup>6\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Enyu Hong,\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Enyu Hong\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Yongbo Yu,,\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Yongbo Yu\u003Csup>1,2,3\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/1371032\" class=\"user-id-1371032\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/1371032/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Jie Lu,,\">Jie Lu\u003C/a>\u003Csup>1,2,3\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Yan Chang,,\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Yan Chang\u003Csup>1,2,3\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/925887\" class=\"user-id-925887\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/925887/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Xin Ni,,\">Xin Ni\u003C/a>\u003Csup>1,2,3\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Min Xu*\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Min Xu\u003Csup>7*\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/557812\" class=\"user-id-557812\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/557812/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Tieliu Shi*\">Tieliu Shi\u003C/a>\u003Csup>4*\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/1155881\" class=\"user-id-1155881\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/1155881/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Yongli Guo,,*\">Yongli Guo\u003C/a>\u003Csup>1,2,3*\u003C/sup>\u003C/span>\u003C/div>\r\n\u003Cul class=\"notes\">\r\n\u003Cli>\u003Cspan>\u003Csup>1\u003C/sup>\u003C/span>Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Children&#x2019;s Health, Beijing Children&#x2019;s Hospital, Beijing Pediatric Research Institute, Capital Medical University, Beijing, China\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>2\u003C/sup>\u003C/span>Biobank for Clinical Data and Samples in Pediatric, National Center for Children&#x2019;s Health, Beijing Children&#x2019;s Hospital, Beijing Pediatric Research Institute, Capital Medical University, Beijing, China\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>3\u003C/sup>\u003C/span>Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Capital Medical University, Beijing, China\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>4\u003C/sup>\u003C/span>Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, Shanghai, China\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>5\u003C/sup>\u003C/span>Department of Surgical Oncology, National Center for Children&#x2019;s Health, Beijing Children&#x2019;s Hospital, Capital Medical University, Beijing, China\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>6\u003C/sup>\u003C/span>Department of Pathology, National Center for Children&#x2019;s Health, Beijing Children&#x2019;s Hospital, Capital Medical University, Beijing, China\u003C/li>\r\n\u003Cli>\u003Cspan>\u003Csup>7\u003C/sup>\u003C/span>Department of Surgery, Shanghai Children&#x2019;s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China\u003C/li>\r\n\u003C/ul>\r\n\u003Cp class=\"mb15\">\u003Cb>Objectives:\u003C/b> To investigate the genetic variants that are responsible for peripheral neuroblastic tumors (PNTs) oncogenesis in one family case.\u003C/p>\r\n\u003Cp class=\"mb15\">\u003Cb>Materials and Methods:\u003C/b> One family was recruited, including the healthy parents, sister affected by neuroblastoma (NB), and brother who suffered from ganglioneuroma (GN). Whole-genome sequencing (WGS) of germline DNA from all the family members and RNA-seq of tumor RNA from the siblings were performed. Mutants were validated by Sanger sequencing and co-IP was performed to assess the impact of the mutant on chemosensitivity in the SH-SY5Y cell line.\u003C/p>\r\n\u003Cp class=\"mb15\">\u003Cb>Results:\u003C/b> A novel compound heterozygous mutation of \u003Ci>BRCA2\u003C/i> was locked as the cause of carcinogenesis. One allele was BRCA2-S871X (stop-gain) from the siblings&#x2019; mother, the other was BRCA2-N372H (missense) from their father. This novel compound heterozygous mutations of the \u003Ci>BRCA2\u003C/i> gene associated with PNTs by disordering DNA damage and response (DDR) signal pathway. Moreover, chemosensitivity was reduced in the NB cell line due to the BRCA2-N372H mutant.\u003C/p>\r\n\u003Cp class=\"mb0\">\u003Cb>Conclusion:\u003C/b> In summary, these results revealed a novel germline compound heterozygous mutation of the \u003Ci>BRCA2\u003C/i> gene associated with familial PNTs.\u003C/p>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003C/div>\r\n\u003Cdiv class=\"JournalFullText\">\r\n\u003Ca id=\"h2\" name=\"h2\">\u003C/a>\u003Ch2>Introduction\u003C/h2>\r\n\u003Cp class=\"mb15\">Peripheral neuroblastic tumors (PNTs), which account for 7&#x2013;10% of all tumors in children, arise from primitive sympathogonia (\u003Ca href=\"#B23\">Luksch et al., 2016\u003C/a>). The PNTs encompass the histologic variants neuroblastoma (NB), ganglioneuroblastoma (GNB), and ganglioneuroma (GN). As tumors of the sympathetic nervous system, they arise wherever sympathetic tissue exists with a predilection for the adrenal gland and retro peritoneum. The biggest difference among these three tumors is the differentiation of tumor cells and prognosis. NB is the most undifferentiated and malignant tumor of the three. As a rare pediatric cancer, NB affects 10.2 per million children under 15 years of age and accounts for 15% of cancer deaths in children (\u003Ca href=\"#B5\">Cheung and Dyer, 2013\u003C/a>). The most benign tumor is GN, which is composed of well-differentiated gangliocytes and mature stroma (\u003Ca href=\"#B21\">Lonergan et al., 2002\u003C/a>). A familial history of NB is very rare, which is reported in about 1% of patients (\u003Ca href=\"#B14\">Janoueix-Lerosey et al., 2010\u003C/a>). Missense and frameshift mutations of \u003Ci>PHOX2B\u003C/i> and activating mutations of \u003Ci>ALK\u003C/i> have been identified in NB families firstly (\u003Ca href=\"#B32\">Trochet et al., 2004\u003C/a>; \u003Ca href=\"#B25\">Mosse et al., 2008\u003C/a>). Furthermore, an increasing number of susceptibility genes have been observed in NB families, such as \u003Ci>NBPF1\u003C/i>, \u003Ci>NBPF23\u003C/i>, \u003Ci>BARD\u003C/i>, and \u003Ci>BRCA2\u003C/i> (\u003Ca href=\"#B28\">Ritenour et al., 2018\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb15\">BRCA2 was first revealed to be involved in the homologous recombination (HR) repair pathway depending on interacting with the recombination protein RAD51. For DNA double-strand breaks (DSBs), HR is a high-fidelity mechanism of repair. As one of fifteen Fanconi anemia (FA) genes, BRCA2 also participates in the HR step in inter-strand crosslinks (ICLs) repair depending on RAD51. According to a previous study, about half of the cases of early-onset breast cancer are due to different inherited mutations in the \u003Ci>BRCA2\u003C/i> gene (\u003Ca href=\"#B33\">Valencia et al., 2017\u003C/a>). In pediatrics, two BRCA2 germline mutations associated with NB have been reported to date. One is BRCA2 p. W2830_E20splice detected from 56 children with NB (\u003Ca href=\"#B38\">Zhang et al., 2015\u003C/a>); the other is BRCA2 p. Y2215fs\u003Csup>&#x2217;\u003C/sup> identified from one NB family (\u003Ca href=\"#B4\">Cai et al., 2017\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">In this study, a new compound heterozygous mutation of the \u003Ci>BRCA2\u003C/i> gene was discovered in two siblings with PNTs by applying WGS technology. One of the biallelic mutations was \u003Ci>BRCA2\u003C/i> rs397507634 chr13: 32911104C &#x003E; A (S871Ter), which was previously found from the screening of the BRCA1/2 genes (\u003Ca href=\"#B2\">Alter, 2014\u003C/a>). However, there are no reports on the relationship between this stop-gain mutant and diseases including PNTs. The other was a missense mutant \u003Ci>BRCA2\u003C/i> rs144848 chr13:32906729A &#x003E; C (N372H). Although it was identified as highly related to breast cancer (\u003Ca href=\"#B12\">Healey et al., 2000\u003C/a>), ovarian cancer (\u003Ca href=\"#B35\">Wenham et al., 2003\u003C/a>), and other many kinds of cancers (\u003Ca href=\"#B30\">Rudd et al., 2006\u003C/a>; \u003Ca href=\"#B27\">Ramus et al., 2008\u003C/a>), there is no report on whether this missense mutant is associated with PNTs. The healthy parents harbored one different allele mutant of \u003Ci>BRCA2\u003C/i> separately. Unfortunately, the two children both inherited the two mutants from their parents and the novel compound heterozygous mutant of \u003Ci>BRCA2\u003C/i> led to PNTs. The evidence in this study may explain how both of the children suffer from the disease despite the absence of PNTs in their parents.\u003C/p>\r\n\u003Ca id=\"h3\" name=\"h3\">\u003C/a>\u003Ch2>Materials and Methods\u003C/h2>\r\n\u003Ch3 class=\"pt0\">Patients and Samples\u003C/h3>\r\n\u003Cp class=\"mb0\">This study included two young patients who were an elder sister (age at diagnosis was 30 months, II-1), and younger brother (age at diagnosis was 36 months, II-2), and their healthy parents (age at 30 s, I-1 and I-2), as shown in \u003Ca href=\"#F1\">Figure 1A\u003C/a>. All patients&#x2019; parents signed informed consent and this study obtained approval from the Institution&#x2019;s Research Ethics Board of Hospital. DNeasy Blood and Tissue Kit (QIAGEN) was used for extracting genomic DNA from blood samples of the younger brother (II-2) and the parents (I-1 and I-2), and the tumor tissue of the siblings (II-1 and II-2). The elder sister&#x2019;s tissue DNA was substituted for her genomic DNA from blood to analyze germline mutants accompanying other family members because her blood was unavailable because she had passed away when this study was conducted. DNA concentration was measured by Qubit\u003Csup>&#x00AE;\u003C/sup> DNA Assay Kit in Qubit\u003Csup>&#x00AE;\u003C/sup> 2.0 Fluorometer (Life Technologies, Carlsbad, CA, United States). RNA of the two patients&#x2019; tumor tissue was extracted by TRzol (\u003Ca href=\"#B10\">Geng et al., 2019\u003C/a>).\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 1\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg\" name=\"figure1\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg\" alt=\"www.frontiersin.org\" id=\"F1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 1.\u003C/strong> The two-generation pedigree of the family and pathological diagnosis of the PNTs siblings. \u003Cb>(A)\u003C/b> Solid symbols (squares = males, circles = females) indicate clinically affected individuals, and open symbols indicate unaffected individuals. \u003Cb>(B)\u003C/b> Histological study confirmed the type of PNTs. II-1 shows the immature neuroblastic tissue from NB after chemotherapy (H&#x0026;E 100 &#x00D7;). II-2 shows mature ganglion cells with abundant cytoplasm in a GN (H&#x0026;E 50&#x00D7;).\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ch3>Whole Genome Sequencing\u003C/h3>\r\n\u003Cp class=\"mb0\">A total of 0.5 &#x03BC;g of DNA per sample was used as input material for the DNA library preparations. Genomic libraries were prepared using the Illumina Truseq Nano DNA HT Sample Prep Kit following the manufacturer&#x2019;s instructions. Libraries were analyzed for size distribution by Agilent 2100 Bioanalyzer. The clustering of the index-coded samples was performed on a cBot Cluster Generation System using Hiseq X PE Cluster Kit V2.5 (Illumina, San Diego, CA, United States) according to the manufacturer&#x2019;s instructions. Then, the DNA libraries were sequenced on the Illumina Hiseq platform and 150 bp paired-end reads were generated.\u003C/p>\r\n\u003Ch3>Read Mapping and Variant Calling\u003C/h3>\r\n\u003Cp class=\"mb0\">Reads after quality control were aligned to the UCSC human reference genome (GRCh37/hg19 assembly) using BWA 0.7.12-r1039 mem mode. Samtools-0.1.18 was used for sorting and removing PCR duplicates, and building an index for the bam files. Variants were called using the VarScan (version 2.3.9) pipeline (\u003Ca href=\"#B24\">McKenna et al., 2010\u003C/a>).\u003C/p>\r\n\u003Ch3>Variant Annotation and Prioritization\u003C/h3>\r\n\u003Cp class=\"mb0\">The resulting variants were annotated and prioritized by ANNOVAR (\u003Ca href=\"#B34\">Wang et al., 2010\u003C/a>). A threshold of minor allele frequency (MAF &#x003C; 0.01) from the 1000 Genomes Project Asian (\u003Ca href=\"#B7\">Devuyst, 2015\u003C/a>) and ExAC (\u003Ca href=\"#B18\">Lek et al., 2016\u003C/a>) non-TCGA cohorts was used to screen rare variants. The pathogenicity of rare missense variants was evaluated by SIFT (\u003Ca href=\"#B19\">Li and Durbin, 2009\u003C/a>), PolyPhen2 (\u003Ca href=\"#B1\">Adzhubei et al., 2013\u003C/a>), MutationTaster (\u003Ca href=\"#B31\">Schwarz et al., 2014\u003C/a>), and M-CAP (\u003Ca href=\"#B13\">Jagadeesh et al., 2016\u003C/a>; \u003Ca href=\"#B20\">Li et al., 2019\u003C/a>). Other rare variants, including frameshift, prematurely truncating, and initial codon variants were also retained for further analysis.\u003C/p>\r\n\u003Ch3>Amplification and Sanger Sequencing of Mutation Sites\u003C/h3>\r\n\u003Cp class=\"mb0\">The two mutations in \u003Ci>BRCA2\u003C/i> were amplified by PCR with a Veriti 96-well Thermal Cycler (Applied Biosystems, Thermo Fisher Scientific). The primer sequences used were as follows: BRCA2-N372H (rs144848) F: 5&#x2032;-CTGAAGTGGAACCAAATGATACTGA-3&#x2032;, R: 5&#x2032;-AGACGGTACAACTTCCTTGGAGAT-3&#x2032; \u003Ca href=\"#B35\">Wenham et al., 2003\u003C/a>); and BRCA2&#x2013;S871X (rs397507634) F: 5&#x2032;- AGTGGAATACAGTGATACTGAC -3&#x2032;, R: 5&#x2032;- TCGTTTACACAAGTCAAGTCTG -3&#x2032;. Mutations were confirmed by Sanger sequencing (\u003Ca href=\"#B3\">Bao et al., 2019\u003C/a>).\u003C/p>\r\n\u003Ch3>Differential Expression Analysis and KEGG Pathway Enrichment Analysis\u003C/h3>\r\n\u003Cp class=\"mb0\">RNA-seq data were aligned to the UCSC human reference genome (GRCh37/hg19 assembly) using Hisat2 2.0.1 (\u003Ca href=\"#B15\">Kim et al., 2015\u003C/a>). Expression of genes (raw count) was quantified by StingTie 1.3.5 (\u003Ca href=\"#B26\">Pertea et al., 2015\u003C/a>). Differentially expressed genes between different conditions were selected using R package DESeq2 based on the criteria of parameter: fold change &#x003E; 2 and FDR &#x003C; 0.05 (\u003Ca href=\"#B22\">Love et al., 2014\u003C/a>). KEGG pathway enrichment analysis of differentially expressed genes was carried out using the R package clusterProfiler (\u003Ca href=\"#B37\">Yu et al., 2012\u003C/a>). Only those pathways with adjusted \u003Ci>P\u003C/i>-value &#x003C; 0.05 were considered statistically significant.\u003C/p>\r\n\u003Ch3>Plasmids and Reagents\u003C/h3>\r\n\u003Cp class=\"mb15\">The p3xFlag-GV141-P/CAF plasmid was purchased from Shanghai GeneChem Co., Ltd. The fragment of BRCA2-290-453aa-wildtype was cloned from pDEST26 -BRCA2 gifted from Dr. Dongyi Xu (Peking University). Using BM seamless cloning kit (Biomed, China), the truncation was cloned into pXJ40-HA. The construct with a mutation in BRCA2-290-453aa-N372H was generated as described previously (\u003Ca href=\"#B36\">Yang et al., 2015\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">Anti-Flag M2 agarose affinity gel and mouse monoclonal antibody against Flag was purchased from Sigma (St. Louis, MO, United States). Antibody against HA and antibody against 53BP1 were from Abcam.\u003C/p>\r\n\u003Ch3>Cell Culture and Reagents\u003C/h3>\r\n\u003Cp class=\"mb0\">SH-SY5Y cells were obtained from the American Type Culture Collection (Rockville, MD, United States). The cell line was grown in DMEM medium supplemented with 10% fetal bovine serum at 37&#x00B0;C in the presence of 5% CO2. For transient transfection experiments, cells were transfected with indicated constructs, using Lipofectamin 3000 (Invitrogen) following the manufacturer&#x2019;s protocols.\u003C/p>\r\n\u003Ch3>Coimmunoprecipitation and Western Blotting\u003C/h3>\r\n\u003Cp class=\"mb0\">SH-SY5Y cells transfected with p3xFlag-GV141-P/CAF and pXJ40-HA- BRCA2-290-453aa-WT or pXJ40-HA-BRCA2-290-453aa-N372H were harvested and immunoprecipitation with anti-Flag M2 agarose was performed using whole cell lysates as described previously (\u003Ca href=\"#B34\">Wang et al., 2010\u003C/a>). For the drug treatment group, 1 &#x03BC;M final concentration of Adriamycin (ADR) (Sigma) was added into the cell culture medium for 6 h before harvesting the whole cell lysis. Samples were separated by SDS-PAGE and detected by immunoblotting with indicated antibodies.\u003C/p>\r\n\u003Ca id=\"h4\" name=\"h4\">\u003C/a>\u003Ch2>Results\u003C/h2>\r\n\u003Ch3 class=\"pt0\">Clinical Features\u003C/h3>\r\n\u003Cp class=\"mb0\">A 30-month-old Chinese girl (the proband, elder sister, and II-1; \u003Ca href=\"#F1\">Figure 1\u003C/a>) was diagnosed with NB, which primary site was retroperitoneum, in Shanghai Children&#x2019;s Medical Center (SCMC) Affiliated to Shanghai Jiao Tong University. Serum neuron-specific enolase (NSE), serum lactate dehydrogenase (LDH), urinary vanillylmandelic acid (VMA), and urinary homovanillic acid (HVA) were all significantly elevated. The patient was diagnosed with high risk NB at stage M, with metastasis to bone and bone marrow, according to the international Neuroblastoma Risk Group (INRG) staging and risk system. Complying with SCMC-NB-2009 treatment protocol (\u003Ca href=\"#B4\">Cai et al., 2017\u003C/a>), the proband was treated with chemotherapy before removing the primary tumor. After surgery, the proband was determined to be NB by pathological examination (\u003Ca href=\"#F1\">Figure 1B\u003C/a>) according to international Neuroblastoma Pathology Classification (INPC). \u003Ci>MYCN\u003C/i> status, 1p36, and 11q23 were all normal without amplification or deletion. Although the myeloablative therapy, autologous stem cell transplant, radiation, and isotretinoin were following applied, the girl was recurrent after 26 months from the first diagnosis with NB. Then the proband accepted additional chemotherapy and allogeneic hematopoietic stem cell transplantation. Unfortunately, the patient died 53 months after the final onset of illness (\u003Ca href=\"#T1\">Table 1\u003C/a>).\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">TABLE 1\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg\" name=\"table1\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-t001.jpg\" alt=\"www.frontiersin.org\" id=\"T1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Table 1.\u003C/strong> Clinical characteristics of two patients with peripheral neuroblastic tumors.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cp class=\"mb15 w100pc float_left mt15\">The second case was the proband&#x2019;s younger brother (63 months younger than his sister, II-2, and \u003Ca href=\"#F1\">Figure 1\u003C/a>). He was 36 months old at the time of diagnosis with GN, which is the same origin as NB but one benign type of PNTs in Beijing Children Hospital Affiliated with Capital Medical University. Unlike his sister, the tumor was in the adrenal gland. Serum NSE, serum LDH, urinary VMA, and urinary HVA were all normal. Besides, \u003Ci>MYCN\u003C/i> status, 1p36, and 11q23 were also normal without amplification or deletion, which was the same as his sister. The patient was diagnosed with very low risk GN at stage L1, according to the INRG staging and risk system. On account of this being a benign tumor, the treatment schedule only included surgery and observation, and no recurrence as yet (\u003Ca href=\"#T1\">Table 1\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">Information on the three generations of this family was collected. The grandfather of the proband died from liver cancer, and the grandmother is alive but suffering from gastric carcinoma and thyroid cancer. The maternal grandfather of the proband had Alzheimer&#x2019;s, and the maternal grandmother lives with benign thyroid nodules. Other family members are healthy, including the father&#x2019;s sister and her two children. The parents stated normal pregnancies and deliveries without any adverse event for the siblings.\u003C/p>\r\n\u003Ch3>Whole-Genome Sequencing Analysis and Pathogenic Variants Validating\u003C/h3>\r\n\u003Cp class=\"mb15\">The fact that the siblings in the same family suffered from PNTs strongly suggested that their carcinogenesis was caused by germline variants. Therefore, to identify the causative variants contributing to the carcinogenesis, we performed high-coverage and high-quality WGS of all family members (father, mother, sister, and brother). Specifically, more than 91.4% of the whole genome had 10-fold coverage and showed high consistency among the experiments. In addition, more than 89% of sequenced bases reached Q\u003Csub>30\u003C/sub> based on the analysis of the Phred-scaled quality score (\u003Ca href=\"#S12\">Supplementary Tables 1\u003C/a>, \u003Ca href=\"#S12\">2\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb0\">The variant calling analysis identified about 4.4 million variants in each family member (\u003Ca href=\"#S12\">Supplementary Table 2\u003C/a>). Of these, a total of shared 47088 rare variants of the siblings and their mother were selected based on MAF &#x003C; 0.01. Furthermore, exonic non-synonymous variants were analyzed and 185 rare variants inherited from the mother were selected. Finally, among rare variants from the mother, as cancer driver genes, a missense mutant \u003Ci>ALK\u003C/i> (chr2: 30143039G &#x003E; T, V163L, rs55697431), and a stop-gain mutant \u003Ci>BRCA2\u003C/i> (chr13: 32911104C &#x003E; A, S871Ter, rs397507634) were focused through screening using the IntOGen database (\u003Ca href=\"#F2\">Figure 2A\u003C/a>). For ALK-V163L, multiple databases predicted that it was a benign mutation although \u003Ci>ALK\u003C/i> is one of the most famous susceptibility genes for NB (\u003Ca href=\"#S12\">Supplementary Table 3\u003C/a>).\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 2\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg\" name=\"figure2\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g002.jpg\" alt=\"www.frontiersin.org\" id=\"F2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 2.\u003C/strong> \u003Cb>(A)\u003C/b> Workflow for the identification of pathogenic mutations. \u003Cb>(B)\u003C/b> Schematic diagram of genetic pattern.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cp class=\"mb15 w100pc float_left mt15\">Meanwhile, the same strategy was performed to select shared rare variants of the siblings and their father (\u003Ca href=\"#F2\">Figure 2A\u003C/a>). However, there was no same gene between the mother and father by this strategy (data not shown). Knudson&#x2019;s &#x201C;two-hit&#x201D; theory, one susceptibility gene carried different mutants from mother and father separately. Further analysis revealed that they shared total variants gained from father (no MAF value limitation), and a missense mutant \u003Ci>BRCA2\u003C/i> (chr13:32906729A &#x003E; C, N372H, rs144848) was selected. Although BRCA2-N372H is a common variant (C = 0.279642, GnomAD_exome) inherited from the father, it induced a novel compound heterozygous mutation of \u003Ci>BRCA2\u003C/i>, and combining with a stop-gain mutant BRCA2-S871Ter inherited from the mother. In other words, one allele was BRCA2-S871Ter (stop-gain) from the sibling&#x2019;s mother, and the other was BRCA2-N372H (missense) from the father (\u003Ca href=\"#F2\">Figure 2B\u003C/a> and \u003Ca href=\"#S12\">Supplementary Table 3\u003C/a>). These two mutants of \u003Ci>BRCA2\u003C/i> were confirmed in the four persons by Sanger sequencing (\u003Ca href=\"#F3\">Figure 3A\u003C/a>). In a word, the novel compound heterozygous mutation \u003Ci>BRCA2\u003C/i> gene was locked as the cause of carcinogenesis.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 3\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg\" name=\"figure3\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g003.jpg\" alt=\"www.frontiersin.org\" id=\"F3\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 3.\u003C/strong> Sanger sequencing validation and functional domains of full-length and mutant BRCA2 protein. \u003Cb>(A)\u003C/b> Sanger sequencing confirmed the mutations of \u003Ci>BRCA2\u003C/i>. The two patients (II-1 and II-2) carried both of these two variants. The father carried BRCA2-N372H, while the mother carried BRCA2-S871Ter. \u003Cb>(B)\u003C/b> The full-length BRCA2 protein harbors six functional domains, including PALB2 binding domain, P/CAF binding domain, BRCTs repeat region, Helical domain, OB folds, and TR2 domain. BRCA2-N372H mutant is in the P/CAF binding domain; while the BRCA2-S871Ter variant results in premature truncation at the 871st amino acid of BRCA2 protein, which only includes the PALB2 and P/CAF binding domains.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ch3>BRCA2-S871Ter Mutant Mechanistic Association With PNTs\u003C/h3>\r\n\u003Cp class=\"mb15\">As a stop-gain mutation, rs397507634 (S871Ter) in \u003Ci>BRCA2\u003C/i> was found first by quantitative polymerase chain reaction and high-resolution melting curve analysis (\u003Ca href=\"#B6\">Coulet et al., 2010\u003C/a>). This variation resulted in premature truncation at the 871st amino acid of the BRCA2 protein, which only includes the PALB2 and P/CAF binding domains (\u003Ca href=\"#F3\">Figure 3B\u003C/a>). Based on ClinVar annotation, rs397507634 in \u003Ci>BRCA2\u003C/i> is related to hereditary breast and ovarian cancer syndrome (RCV000590670.1), breast-ovarian cancer, familial 2 (RCV000077282.4), and hereditary cancer-predisposing syndrome (RCV000213349.1).\u003C/p>\r\n\u003Cp class=\"mb0\">By mining for the potential impact of stop-gain mutant BRCA2-S871Ter, differentially expressed genes were obtained from RNA-seq data of patients&#x2019; tumor tissue (\u003Ca href=\"#S12\">Supplementary Table 4\u003C/a>) and the GEO database GSE62564. There are four samples carrying BRCA2-N372H without BRCA2-S871Ter in the GSE62564 database, including three samples with homozygous mutant (NB_380, NB_390, and NB_438) and one sample with heterozygous mutant (NB_459). KEGG pathway enrichment analysis based on differential genes was performed between siblings and these four samples from the GSE62564 database. The result showed that the significant enriched KEGG pathway included DNA replication, cell cycle, and HR, which were identified with the molecular functions of BRCA2 (\u003Ca href=\"#F4\">Figure 4A\u003C/a>).\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 4\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg\" name=\"figure4\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g004.jpg\" alt=\"www.frontiersin.org\" id=\"F4\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 4.\u003C/strong> KEGG pathway enrichment analysis of differentially expressed genes. \u003Cb>(A)\u003C/b> To analyze the contribution of stop-gain mutant BRCA2-S871Ter, analysis based on differential genes obtaining from RNA-seq data was performed between siblings and four samples with BRCA2-N372H variant belonging to the GSE62564 database. \u003Cb>(B)\u003C/b> To reveal whether the compound heterozygous mutant of \u003Ci>BRCA2\u003C/i> contributed to the PNTs, we compared the siblings&#x2019; RNA-seq data, and 494 cases without either BRCA2-N372H or S871Ter mutant from the GSE62564 database.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cp class=\"mb15 w100pc float_left mt15\">Besides, BRCA2-S871Ter led to early termination during BRCA2 protein translation and produced a 1&#x2013;871 amino acid truncation of BRCA2 or even led to degradation of BRCA2. To simulate the functions of BRCA2-S871Ter, the GSE62564 dataset (498 samples) was analyzed. Samples with the top 25% (BRCA2 high group) and the lowest 25% (BRCA2 low group) expression of \u003Ci>BRCA2\u003C/i> were taken separately. KEGG pathway enrichment analysis based on these two groups was performed (\u003Ca href=\"#S12\">Supplementary Figure 1\u003C/a>). The results also revealed that pathways of the cell cycle, DNA replication, and HR were enriched significantly.\u003C/p>\r\n\u003Ch3>BRCA2-N372H Mutant Mechanistic Association With PNTs\u003C/h3>\r\n\u003Cp class=\"mb0\">In addition to the BRCA2 premature truncating mutant, a missense variant rs144848 (N372H) of \u003Ci>BRCA2\u003C/i> inherited from proband&#x2019;s mother was considered a pathogenic variant. It has been reported to increase the risk of many kinds of cancers, especially breast and epithelial ovarian, and indicating that the variant could increase cancer susceptibility. However, there was no report that BRCA2-N372H was associated with neuroblastic tumors. This mutant locates in the P/CAF binding domain (residues 290&#x2013;453) of BRCA2 (\u003Ca href=\"#F3\">Figure 3B\u003C/a>). This domain has been shown to mediate the interaction between BRCA2 and the histone acetyltransferase P/CAF. The formation of the BRCA2-P/CAF complex is essential for the transcriptional activation of other genes (\u003Ca href=\"#B9\">Fuks et al., 1998\u003C/a>). Co-IP was performed and showed that BRCA2-N372H substitution did not affect the interaction between BRCA2 and P/CAF absenting chemotherapeutics drug (\u003Ca href=\"#F5\">Figure 5B\u003C/a>). To determine the optimum concentration and time of treatment with ADR, SH-SY5Y was treated with 1 &#x03BC;M ADR at a different time and then detected the expression of 53BP1 by WB. The results showed that 1 &#x03BC;M ADR treated for 6 h could induce the expression of 53BP1, which was enhanced significantly (\u003Ca href=\"#F5\">Figure 5A\u003C/a>). Remarkably, after the same condition of ADR treatment (1 &#x03BC;M, 6 h), the interaction between BRCA2 and P/CAF was reduced significantly due to the N372H mutant in the SH-SY5Y cell line (\u003Ca href=\"#F5\">Figure 5B\u003C/a>). The results suggest that the BRCA2-N372H mutant could destroy the function of P/CAF in the context of DNA damage.\u003C/p>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Cdiv class=\"Imageheaders\">FIGURE 5\u003C/div>\r\n\u003Cdiv class=\"FigureDesc\">\r\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg\" name=\"figure5\" target=\"_blank\">\r\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g005.jpg\" alt=\"www.frontiersin.org\" id=\"F5\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\r\n\u003Cp>\u003Cstrong>Figure 5.\u003C/strong> Co-IP between BRCA2 and P/CAF. \u003Cb>(A)\u003C/b> The optimum concentration and time of treatment with ADR in SH-SY5Y to induce DNA double-strand breaks. 1 &#x03BC;M ADR treated with 6 h could induce the expression of 53 bp1 enhanced significantly. \u003Cb>(B)\u003C/b> Co-IP showed that BRCA2-N372H substitution reduced the interaction between BRCA2 and P/CAF with the treatment of ADR (1 &#x03BC;M and 6 h). SH-SY5Y cells were transfected with plasmids expressing Flag-p/CAF and HA-BRCA2-266-453-WT or HA-BRCA2-266-453-N372H and analyzed by co-IP with or without ADR treatment. Immunoprecipitates were analyzed by western blot with antibodies against Flag or HA.\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003Cdiv class=\"DottedLine\">\u003C/div>\r\n\u003Ch3>Dysfunctional BRCA2 Due to \u003Ci>BRCA2\u003C/i> Mutants\u003C/h3>\r\n\u003Cp class=\"mb15\">To reveal the compound heterozygous of \u003Ci>BRCA2\u003C/i> was contributed to PNTs&#x2019; carcinogenesis, KEGG pathway enrichment analysis was performed between the siblings&#x2019; RNA-seq data and 494 cases without either BRCA2-S871Ter or BRCA2-N372H mutants from the GSE62564 database. It was shown that the pathways of the cell cycle, DNA replication, FA pathway, and HR were enriched. (\u003Ca href=\"#F4\">Figure 4B\u003C/a>). It indicated that the compound heterozygous of \u003Ci>BRCA2\u003C/i> resulted in the disordering of BRCA2 protein&#x2019;s function of DNA damage and response (DDR), which was the reason two child patients suffered PNTs.\u003C/p>\r\n\u003Cp class=\"mb0\">To simulate the functions of the new compound heterozygous of \u003Ci>BRCA2\u003C/i>, the GSE62564 dataset (498 samples) was analyzed and the one intersection of samples with the top 25% expression of both \u003Ci>BRCA2\u003C/i> and \u003Ci>P/CAF\u003C/i> (BRCA2-P/CAF high group, 36 samples) was taken. Meanwhile, samples with the lowest 25% expression of both \u003Ci>BRCA2\u003C/i> and \u003Ci>P/CAF\u003C/i> were taken as the other intersection from GSE62564 (BRCA2-P/CAF low group, 39 samples). KEGG pathway enrichment analysis was performed between the two intersections (\u003Ca href=\"#S12\">Supplementary Figure 2\u003C/a>). The results also revealed that pathways of the cell cycle, DNA replication, FA pathway, and HR pathways were enriched significantly, which was similar to our previous results (\u003Ca href=\"#F4\">Figure 4B\u003C/a>).\u003C/p>\r\n\u003Ca id=\"h5\" name=\"h5\">\u003C/a>\u003Ch2>Discussion\u003C/h2>\r\n\u003Cp class=\"mb15\">\u003Ci>BRCA2\u003C/i>, a principal tumor suppressor gene, is involved in DNA damage repair and related to many types of cancer susceptibility, especially breast cancer, and ovarian cancer in adults (\u003Ca href=\"#B29\">Rousset-Jablonski and Gompel, 2017\u003C/a>; \u003Ca href=\"#B8\">Flaum et al., 2019\u003C/a>). Meanwhile, as one of the FA DNA repair-related genes, some specific \u003Ci>BRCA2\u003C/i> mutants lead to a severe subset FA accompanying the early onset of cancer, including acute myeloid leukemia, brain tumors, Wilms tumor, and so on (\u003Ca href=\"#B2\">Alter, 2014\u003C/a>). In pediatrics, BRCA2 p. W2830_E20splice and p. Y2215fs\u003Csup>&#x2217;\u003C/sup> are the only two \u003Ci>BRCA2\u003C/i> germline mutations to have been reported to associate with NB (\u003Ca href=\"#B38\">Zhang et al., 2015\u003C/a>; \u003Ca href=\"#B4\">Cai et al., 2017\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb15\">This study revealed a new compound heterozygotes mutant of \u003Ci>BRCA2\u003C/i> by employing WGS of germline DNA in two siblings with PNTs and their unaffected parents. A stop-gain mutant BRCA2-S871Ter inherited from the mother and a missense mutant BRCA2-N372H inherited from the father were validated by Sanger sequencing (\u003Ca href=\"#F3\">Figure 3A\u003C/a>). According to Knudson&#x2019;s &#x201C;two-hit&#x201D; theory (\u003Ca href=\"#B16\">Knudson, 1996\u003C/a>) and KEGG pathway enrichment analysis (\u003Ca href=\"#F4\">Figure 4B\u003C/a> and \u003Ca href=\"#S12\">Supplementary Figure 2\u003C/a>), our results provide useful information that this novel compound heterozygotes mutant of \u003Ci>BRCA2\u003C/i> could be the cause of carcinogenesis and a potential biomarker for PNTs.\u003C/p>\r\n\u003Cp class=\"mb15\">For the stop-gain mutant, inherited from the mother of the siblings, BRCA2-S871Ter is a rare frequency variation, which has been found through qPCR-HRM based on 210 patients (\u003Ca href=\"#B6\">Coulet et al., 2010\u003C/a>). Moreover, this variation is included in some panels to detect breast cancer or ovarian cancer in clinical settings. It can lead to early termination during BRCA2 protein translation and produce a 1&#x2013;871 amino acids truncation of BRCA2. In this study, western blotting was performed to detect BRCA2 expression in the siblings&#x2019; tumor tissue. Unfortunately, there was no specific signal of BRCA2 in WB (data not shown). The reason for failing to detect BRCA2 might be protein degradation for its large molecular weight. Although it is not certain whether this truncation is expressed or degraded after translation, the fact is that the functions of BRCA2 should be impacted to a great extent. As \u003Ca href=\"#F3\">Figure 3B\u003C/a> shows, the majority of the important domains, including BRCTs domain, helical domain, OB folds, and the TR2 domain, are not in the BRCA2 stop-gain truncation. These domains all play key roles in DNA double strand breaks repair. The BRCTs and OB fold domain are essential to BRCA2 binding to RAD51. Then the BRCA2-RAD51 complex will further promote RAD51 assembly onto single-strand DNA to carry forward HR repair. KEGG pathway enrichment analysis also confirmed the above results about BRCA2-S871Ter (\u003Ca href=\"#F4\">Figure 4A\u003C/a> and \u003Ca href=\"#S12\">Supplementary Figure 1\u003C/a>).\u003C/p>\r\n\u003Cp class=\"mb15\">In addition, BRCA2-N372H is a variant associated with breast cancer and epithelial ovarian cancer (\u003Ca href=\"#B12\">Healey et al., 2000\u003C/a>; \u003Ca href=\"#B35\">Wenham et al., 2003\u003C/a>). Recently, an increasing number of studies have been performed to prove that the BRCA2-N372H variant is related to susceptibility to many other cancers, including multiple lymphoma, prostate cancer, advanced esophageal squamous cell carcinoma, familial colorectal tumors, and so on. Moreover, previous research has shown that BRCA2-N372H is located in the P/CAF binding domain of BRCA2. The domain from residues of amino acid 290&#x2013;453 in the N-terminus of BRCA2 specifically interacts with the histone acetyltransferase P/CAF (\u003Ca href=\"#B9\">Fuks et al., 1998\u003C/a>). P/CAF belongs to the type three family of lysine acetyl transferases (KAT3) (\u003Ca href=\"#B11\">Goodman and Smolik, 2000\u003C/a>). As a transcriptional co-activator, P/CAF binds to transcription factors and performs lysine acetyltransferases activity to acetylate these transcription factors and histones to lose condensed chromosomes. N terminus of BRCA2 is equipped with HAT activity when it bounds to P/CAF. The BRCA2-N372H variation weakens BRCA2 expression and BRCA2-P/CAF interaction and further reduces sensitivity to paclitaxel in breast cancer cells (\u003Ca href=\"#B17\">Kwon et al., 2017\u003C/a>). It indicates that BRCA2 372-His substitution induces sequential changes of BRCA2-P/CAF interaction and HAT activity, which is important in paclitaxel resistance (\u003Ca href=\"#B17\">Kwon et al., 2017\u003C/a>). ADR as the first-line chemotherapy drug to NB therapy could induce DSBs to NB cells. In our study, with ADR treatment, the interaction between BRCA2, and P/CAF was reduced significantly due to the N372H mutant in SH-SY5Y cells (\u003Ca href=\"#F5\">Figure 5\u003C/a>). Meanwhile, BRCA2-N372H substitution could not affect the interaction between BRCA2 and P/CAF without drugs. The results suggested that the BRCA2-N372H mutant could destroy the HAT activity of BRCA2-P/CAF in the context of DNA damage. Furthermore, like the paclitaxel resistance, this mutant could induce ADR resistance to NB cells due to lack of HAT activity. This indicates that the BRCA2-N372H mutant could be a new potential drug target in NB chemotherapy.\u003C/p>\r\n\u003Cp class=\"mb0\">This study explored the reason for different malignant degrees between these two child patients. Firstly, the BRCA2-N372H variant was reported to affect fetal survival in a sex-dependent manner. With the same BRCA2-N372H variant, the survival rate of newborn females was significantly lower than males (\u003Ca href=\"#B12\">Healey et al., 2000\u003C/a>). Secondly, WGS of the two children&#x2019;s tumor tissue did not show enrichment of any distinct carcinogenesis related pathway in specific somatic variants in the siblings, respectively (\u003Ca href=\"#S12\">Supplementary Figure 2\u003C/a>). There were 721 individual mutant genes in the elder sister and 701 individual mutant genes in the brother. However, screening the IntOGen database revealed that the elder sister harbored more specific cancer driver genes than a brother (20 vs. 14 genes), indicating that the sister had a greater chance of developing a malignant tumor (\u003Ca href=\"#S12\">Supplementary Tables 6,7\u003C/a>). Furthermore, RNA-seq analysis based on the two siblings&#x2019; tissue RNA revealed that the row counts of \u003Ci>BRCA2\u003C/i> mRNA expression were 91 in the sister and 898 in the brother (\u003Ca href=\"#S12\">Supplementary Table 5\u003C/a>). Real-time PCR was performed to confirm the relative expression of \u003Ci>BRCA2\u003C/i> in the siblings&#x2019; tumor tissue. It was verified that the expression of \u003Ci>BRCA2\u003C/i> in the sister was significantly lower than in the younger brother (\u003Ca href=\"#S12\">Supplementary Figure 3\u003C/a>). Although the sample size was limited in this study, the siblings harbored similar genetic backgrounds and the same compound heterozygous mutation of \u003Ci>BRCA2\u003C/i>. This indicated that as tumor suppressor genes, a low amount of BRCA2 may lead to cancer susceptibility, and therefore the malignancy degree in the sister was higher than the younger brother. However, the mechanism of different malignant degrees between the siblings needs further study.\u003C/p>\r\n\u003Ca id=\"h6\" name=\"h6\">\u003C/a>\u003Ch2>Conclusion\u003C/h2>\r\n\u003Cp class=\"mb0\">Our data revealed that a novel compound heterozygous mutation of the \u003Ci>BRCA2\u003C/i> gene is associated with PNTs by disordering DDR signal pathway. One allele was stop-gain mutant BRCA2-S871Ter, inherited from their mother. The other was a missense mutant BRCA2-N372H inherited from their father, which was confirmed to impair the interaction between BRCA2 and P/CAF, and induced ADR resistance in NB. Moreover, these results provided potential laboratory evidence for the clinical and prenatal diagnosis of PNTs. These results could also potentially guide clinical precision medication. For further investigation of the genotype-phenotype relationship in PNTs, future efforts should be made to recruit more families affected by this disease, and despite its rarity.\u003C/p>\r\n\u003Ca id=\"h7\" name=\"h7\">\u003C/a>\u003Ch2>Limitations\u003C/h2>\r\n\u003Cp class=\"mb0\">There were some limitations in the present study. Firstly, the sample size was small, due to the study object was only one family with two siblings harboring PNTs. Secondly, we needed to make a credible conclusion by incorporating prior knowledge, because of the rarity of samples. Therefore, to further investigate the genotype-phenotype relationship in PNTs, efforts should be made to recruit more families affected by this disease. Furthermore, to decipher the molecular mechanism of the compound heterozygous of \u003Ci>BRCA2\u003C/i> mutations, more studies, including cell level and animal models, and need to be performed in the future.\u003C/p>\r\n\u003Ca id=\"h8\" name=\"h8\">\u003C/a>\u003Ch2>Data Availability Statement\u003C/h2>\r\n\u003Cp class=\"mb0\">The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: \u003Ca href=\"https://www.biosino.org/node/analysis/detail/OEZ005703\">https://www.biosino.org/node/analysis/detail/OEZ005703\u003C/a>, OEZ005703.\u003C/p>\r\n\u003Ca id=\"h9\" name=\"h9\">\u003C/a>\u003Ch2>Ethics Statement\u003C/h2>\r\n\u003Cp class=\"mb0\">The studies involving human participants were reviewed and approved by Ethics Committee of the Beijing Children&#x2019;s Hospital, Capital Medical University. Written informed consent to participate in this study was provided by the participants&#x2019; legal guardian/next of kin. Written informed consent was obtained from the individual(s), and minor(s)&#x2019; legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.\u003C/p>\r\n\u003Ca id=\"S9\" name=\"S9\">\u003C/a>\u003Ch2>Author Contributions\u003C/h2>\r\n\u003Cp class=\"mb0\">YrY, JC, and HQ conducted the experiments, analyzed the data, and wrote the manuscript. YJ and LZ analyzed the data, reviewed, and edited the manuscript. SY, HW, LF, EH, YbY, JL, YC, and XN conducted the experiments. MX, TS, and YG designed the study, wrote, reviewed, and edited the manuscript, and administrated the project. All authors contributed to the article and approved the submitted version.\u003C/p>\r\n\u003Ca id=\"fun1\" name=\"fun1\">\u003C/a>\u003Ch2>Funding\u003C/h2>\r\n\u003Cp class=\"mb0\">This study was supported by the National Natural Science Foundation of China (81702787, 81702463, and 31671377), the Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Hospitals Authority (No. XTCX201806), Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (XMLX202121), Beijing Hospitals Authority&#x2019; Ascent Plan (DFL20191201), and Shanghai Municipal Science and Technology Major Project (2017SHZDZX01).\u003C/p>\r\n\u003Ca id=\"conf1\" name=\"conf1\">\u003C/a>\u003Ch2>Conflict of Interest\u003C/h2>\r\n\u003Cp class=\"mb0\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p>\r\n\u003Ca id=\"h13\" name=\"h13\">\u003C/a>\u003Ch2>Publisher&#x2019;s Note\u003C/h2>\r\n\u003Cp class=\"mb0\">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003C/p>\r\n\u003Ca id=\"ack1\" name=\"ack1\">\u003C/a>\u003Ch2>Acknowledgments\u003C/h2>\r\n\u003Cp class=\"mb0\">We are grateful to the child patients and their parents for their participation in this study.\u003C/p>\r\n\u003Ca id=\"S12\" name=\"S12\">\u003C/a>\u003Ch2>Supplementary Material\u003C/h2>\r\n\u003Cp class=\"mb15\">The Supplementary Material for this article can be found online at: \u003Ca href=\"https://www.frontiersin.org/articles/10.3389/fgene.2021.652718/full#supplementary-material\">https://www.frontiersin.org/articles/10.3389/fgene.2021.652718/full#supplementary-material\u003C/a>\u003C/p>\r\n\u003Cp class=\"mb15\" id=\"FS1\">\u003Cb>Supplementary Figure 1 &#x007C;\u003C/b> KEGG pathway enrichment analysis of differentially expressed genes between BRCA2 high group and BRCA2 low group from GSE62564 dataset.\u003C/p>\r\n\u003Cp class=\"mb15\" id=\"FS2\">\u003Cb>Supplementary Figure 2 &#x007C;\u003C/b> KEGG pathway enrichment analysis of differentially expressed genes between BRCA2-P/CAF high group and BRCA2-P/CAF low group from GSE62564 dataset.\u003C/p>\r\n\u003Cp class=\"mb15\" id=\"FS3\">\u003Cb>Supplementary Figure 3 &#x007C;\u003C/b> KEGG pathway enrichment analysis of specific somatic variants. \u003Cb>(A)\u003C/b> KEGG pathway enrichment of 721 individual mutant genes in elder sister. \u003Cb>(B)\u003C/b> KEGG pathway enrichment of 701 individual mutant genes in brother.\u003C/p>\r\n\u003Cp class=\"mb0\" id=\"FS4\">\u003Cb>Supplementary Figure 4 &#x007C;\u003C/b> Expression of \u003Ci>BRCA2\u003C/i> in the siblings. Real-time PCR to detect expression of \u003Ci>BRCA2\u003C/i> in the siblings&#x2019; RNA from tumor tissue.\u003C/p>\r\n\u003Ca id=\"refer1\" name=\"refer1\">\u003C/a>\u003Ch2>References\u003C/h2>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B1\" id=\"B1\">\u003C/a>Adzhubei, I., Jordan, D. M., and Sunyaev, S. R. (2013). Predicting functional effect of human missense mutations using PolyPhen-2. \u003Ci>Curr. Protoc. Hum. Genet.\u003C/i> Chapter 7:Unit7.20.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Predicting+functional+effect+of+human+missense+mutations+using+PolyPhen-2%2E&#x0026;journal=Curr%2E+Protoc%2E+Hum%2E+Genet%2E&#x0026;author=Adzhubei+I.&#x0026;author=Jordan+D.+M.&#x0026;author=Sunyaev+S.+R.&#x0026;publication_year=2013&#x0026;volume=Chapter 7&#x0026;issue=Unit7.20\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B2\" id=\"B2\">\u003C/a>Alter, B. P. (2014). Fanconi anemia and the development of leukemia. \u003Ci>Best Pract. Res. Clin. Haematol.\u003C/i> 27, 214&#x2013;221.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Fanconi+anemia+and+the+development+of+leukemia%2E&#x0026;journal=Best+Pract%2E+Res%2E+Clin%2E+Haematol%2E&#x0026;author=Alter+B.+P.&#x0026;publication_year=2014&#x0026;volume=27&#x0026;pages=214&#x2013;221\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B3\" id=\"B3\">\u003C/a>Bao, Y., Suo, L., Qian, P., Huang, H., Yang, Y., Tang, J., et al. (2019). Clinical and genetic analysis of Dent disease with nephrotic range albuminuria in Shaanxi, China. \u003Ci>Sci. China Life Sci.\u003C/i> 62, 1590&#x2013;1593. doi: 10.1007/s11427-018-9829-0\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31701402\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s11427-018-9829-0\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Clinical+and+genetic+analysis+of+Dent+disease+with+nephrotic+range+albuminuria+in+Shaanxi%2C+China%2E&#x0026;journal=Sci%2E+China+Life+Sci%2E&#x0026;author=Bao+Y.&#x0026;author=Suo+L.&#x0026;author=Qian+P.&#x0026;author=Huang+H.&#x0026;author=Yang+Y.&#x0026;author=Tang+J.&#x0026;publication_year=2019&#x0026;volume=62&#x0026;pages=1590&#x2013;1593\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B4\" id=\"B4\">\u003C/a>Cai, J., Pan, C., Tang, Y., Chen, J., Zhou, M., Li, B., et al. (2017). Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China. \u003Ci>J. Cancer Res. Clin. Oncol.\u003C/i> 143, 1327&#x2013;1335. doi: 10.1007/s00432-017-2379-5\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28283783\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00432-017-2379-5\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Multivariate+analysis+of+risk+factors+for+patients+with+stage+4+neuroblastoma+who+were+older+than+18+months+at+diagnosis%3A+a+report+from+a+single+institute+in+Shanghai%2C+China%2E&#x0026;journal=J%2E+Cancer+Res%2E+Clin%2E+Oncol%2E&#x0026;author=Cai+J.&#x0026;author=Pan+C.&#x0026;author=Tang+Y.&#x0026;author=Chen+J.&#x0026;author=Zhou+M.&#x0026;author=Li+B.&#x0026;publication_year=2017&#x0026;volume=143&#x0026;pages=1327&#x2013;1335\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B5\" id=\"B5\">\u003C/a>Cheung, N. K., and Dyer, M. A. (2013). Neuroblastoma: developmental biology, cancer genomics and immunotherapy. \u003Ci>Nat. Rev. Cancer\u003C/i> 13, 397&#x2013;411. doi: 10.1038/nrc3526\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23702928\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nrc3526\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Neuroblastoma%3A+developmental+biology%2C+cancer+genomics+and+immunotherapy%2E&#x0026;journal=Nat%2E+Rev%2E+Cancer&#x0026;author=Cheung+N.+K.&#x0026;author=Dyer+M.+A.&#x0026;publication_year=2013&#x0026;volume=13&#x0026;pages=397&#x2013;411\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B6\" id=\"B6\">\u003C/a>Coulet, F., Pires, F., Rouleau, E., Lefol, C., Martin, S., Colas, C., et al. (2010). A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis. \u003Ci>Genet. Test Mol. Biomark.\u003C/i> 14, 677&#x2013;690. doi: 10.1089/gtmb.2009.0183\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20858050\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1089/gtmb.2009.0183\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=A+one-step+prescreening+for+point+mutations+and+large+rearrangement+in+BRCA1+and+BRCA2+genes+using+quantitative+polymerase+chain+reaction+and+high-resolution+melting+curve+analysis%2E&#x0026;journal=Genet%2E+Test+Mol%2E+Biomark%2E&#x0026;author=Coulet+F.&#x0026;author=Pires+F.&#x0026;author=Rouleau+E.&#x0026;author=Lefol+C.&#x0026;author=Martin+S.&#x0026;author=Colas+C.&#x0026;publication_year=2010&#x0026;volume=14&#x0026;pages=677&#x2013;690\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B7\" id=\"B7\">\u003C/a>Devuyst, O. (2015). The 1000 genomes project: welcome to a new world. \u003Ci>Perit. Dial. Int.\u003C/i> 35, 676&#x2013;677. doi: 10.3747/pdi.2015.00261\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26703842\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3747/pdi.2015.00261\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=The+1000+genomes+project%3A+welcome+to+a+new+world%2E&#x0026;journal=Perit%2E+Dial%2E+Int%2E&#x0026;author=Devuyst+O.&#x0026;publication_year=2015&#x0026;volume=35&#x0026;pages=676&#x2013;677\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B8\" id=\"B8\">\u003C/a>Flaum, N., Crosbie, E. J., Edmondson, R. J., Smith, M. J., and Evans, D. G. (2019). Epithelial ovarian cancer risk: a review of the current genetic landscape. \u003Ci>Clin. Genet.\u003C/i> 97, 54&#x2013;63. doi: 10.1111/cge.13566\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31099061\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/cge.13566\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Epithelial+ovarian+cancer+risk%3A+a+review+of+the+current+genetic+landscape%2E&#x0026;journal=Clin%2E+Genet%2E&#x0026;author=Flaum+N.&#x0026;author=Crosbie+E.+J.&#x0026;author=Edmondson+R.+J.&#x0026;author=Smith+M.+J.&#x0026;author=Evans+D.+G.&#x0026;publication_year=2019&#x0026;volume=97&#x0026;pages=54&#x2013;63\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B9\" id=\"B9\">\u003C/a>Fuks, F., Milner, J., and Kouzarides, T. (1998). BRCA2 associates with acetyltransferase activity when bound to P/CAF. \u003Ci>Oncogene\u003C/i> 17, 2531&#x2013;2534. doi: 10.1038/sj.onc.1202475\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/9824164\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/sj.onc.1202475\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=BRCA2+associates+with+acetyltransferase+activity+when+bound+to+P%2FCAF%2E&#x0026;journal=Oncogene&#x0026;author=Fuks+F.&#x0026;author=Milner+J.&#x0026;author=Kouzarides+T.&#x0026;publication_year=1998&#x0026;volume=17&#x0026;pages=2531&#x2013;2534\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B10\" id=\"B10\">\u003C/a>Geng, J., Liu, Y., Guo, Y., Wang, H., Tai, J., Jin, Y., et al. (2019). Correlation between TERT C228T and clinic-pathological features in pediatric papillary thyroid carcinoma. \u003Ci>Sci. China Life Sci.\u003C/i> 62, 1563&#x2013;1571. doi: 10.1007/s11427-018-9546-5\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31321667\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s11427-018-9546-5\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Correlation+between+TERT+C228T+and+clinic-pathological+features+in+pediatric+papillary+thyroid+carcinoma%2E&#x0026;journal=Sci%2E+China+Life+Sci%2E&#x0026;author=Geng+J.&#x0026;author=Liu+Y.&#x0026;author=Guo+Y.&#x0026;author=Wang+H.&#x0026;author=Tai+J.&#x0026;author=Jin+Y.&#x0026;publication_year=2019&#x0026;volume=62&#x0026;pages=1563&#x2013;1571\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B11\" id=\"B11\">\u003C/a>Goodman, R. H., and Smolik, S. (2000). CBP/p300 in cell growth, transformation, and development. \u003Ci>Genes Dev.\u003C/i> 14, 1553&#x2013;1577.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=CBP%2Fp300+in+cell+growth%2C+transformation%2C+and+development%2E&#x0026;journal=Genes+Dev%2E&#x0026;author=Goodman+R.+H.&#x0026;author=Smolik+S.&#x0026;publication_year=2000&#x0026;volume=14&#x0026;pages=1553&#x2013;1577\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B12\" id=\"B12\">\u003C/a>Healey, C. S., Dunning, A. M., Teare, M. D., Chase, D., Parker, L., Burn, J., et al. (2000). A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. \u003Ci>Nat. Genet.\u003C/i> 26, 362&#x2013;364. doi: 10.1038/81691\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/11062481\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/81691\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=A+common+variant+in+BRCA2+is+associated+with+both+breast+cancer+risk+and+prenatal+viability%2E&#x0026;journal=Nat%2E+Genet%2E&#x0026;author=Healey+C.+S.&#x0026;author=Dunning+A.+M.&#x0026;author=Teare+M.+D.&#x0026;author=Chase+D.&#x0026;author=Parker+L.&#x0026;author=Burn+J.&#x0026;publication_year=2000&#x0026;volume=26&#x0026;pages=362&#x2013;364\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B13\" id=\"B13\">\u003C/a>Jagadeesh, K. A., Wenger, A. M., Berger, M. J., Guturu, H., Stenson, P. D., Cooper, D. N., et al. (2016). M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. \u003Ci>Nat. Genet.\u003C/i> 48, 1581&#x2013;1586. doi: 10.1038/ng.3703\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27776117\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ng.3703\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=M-CAP+eliminates+a+majority+of+variants+of+uncertain+significance+in+clinical+exomes+at+high+sensitivity%2E&#x0026;journal=Nat%2E+Genet%2E&#x0026;author=Jagadeesh+K.+A.&#x0026;author=Wenger+A.+M.&#x0026;author=Berger+M.+J.&#x0026;author=Guturu+H.&#x0026;author=Stenson+P.+D.&#x0026;author=Cooper+D.+N.&#x0026;publication_year=2016&#x0026;volume=48&#x0026;pages=1581&#x2013;1586\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B14\" id=\"B14\">\u003C/a>Janoueix-Lerosey, I., Schleiermacher, G., and Delattre, O. (2010). Molecular pathogenesis of peripheral neuroblastic tumors. \u003Ci>Oncogene\u003C/i> 29, 1566&#x2013;1579. doi: 10.1038/onc.2009.518\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20101209\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/onc.2009.518\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Molecular+pathogenesis+of+peripheral+neuroblastic+tumors%2E&#x0026;journal=Oncogene&#x0026;author=Janoueix-Lerosey+I.&#x0026;author=Schleiermacher+G.&#x0026;author=Delattre+O.&#x0026;publication_year=2010&#x0026;volume=29&#x0026;pages=1566&#x2013;1579\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B15\" id=\"B15\">\u003C/a>Kim, D., Langmead, B., and Salzberg, S. L. (2015). HISAT: a fast spliced aligner with low memory requirements. \u003Ci>Nat. Methods\u003C/i> 12, 357&#x2013;360. doi: 10.1038/nmeth.3317\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25751142\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nmeth.3317\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=HISAT%3A+a+fast+spliced+aligner+with+low+memory+requirements%2E&#x0026;journal=Nat%2E+Methods&#x0026;author=Kim+D.&#x0026;author=Langmead+B.&#x0026;author=Salzberg+S.+L.&#x0026;publication_year=2015&#x0026;volume=12&#x0026;pages=357&#x2013;360\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B16\" id=\"B16\">\u003C/a>Knudson, A. G. (1996). Hereditary cancer: two hits revisited. \u003Ci>J. Cancer Res. Clin. Oncol.\u003C/i> 122, 135&#x2013;140. doi: 10.1007/bf01366952\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/8601560\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/bf01366952\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Hereditary+cancer%3A+two+hits+revisited%2E&#x0026;journal=J%2E+Cancer+Res%2E+Clin%2E+Oncol%2E&#x0026;author=Knudson+A.+G.&#x0026;publication_year=1996&#x0026;volume=122&#x0026;pages=135&#x2013;140\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B17\" id=\"B17\">\u003C/a>Kwon, W. S., Rha, S. Y., Jeung, H. C., Kim, T. S., and Chung, H. C. (2017). Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines. \u003Ci>Biochem. Pharmacol.\u003C/i> 138, 163&#x2013;173. doi: 10.1016/j.bcp.2017.04.015\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28431939\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.bcp.2017.04.015\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Modulation+of+HAT+activity+by+the+BRCA2+N372H+variation+is+a+novel+mechanism+of+paclitaxel+resistance+in+breast+cancer+cell+lines%2E&#x0026;journal=Biochem%2E+Pharmacol%2E&#x0026;author=Kwon+W.+S.&#x0026;author=Rha+S.+Y.&#x0026;author=Jeung+H.+C.&#x0026;author=Kim+T.+S.&#x0026;author=Chung+H.+C.&#x0026;publication_year=2017&#x0026;volume=138&#x0026;pages=163&#x2013;173\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B18\" id=\"B18\">\u003C/a>Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., et al. (2016). Analysis of protein-coding genetic variation in 60,706 humans. \u003Ci>Nature\u003C/i> 536, 285&#x2013;291.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Analysis+of+protein-coding+genetic+variation+in+60%2C706+humans%2E&#x0026;journal=Nature&#x0026;author=Lek+M.&#x0026;author=Karczewski+K.+J.&#x0026;author=Minikel+E.+V.&#x0026;author=Samocha+K.+E.&#x0026;author=Banks+E.&#x0026;author=Fennell+T.&#x0026;publication_year=2016&#x0026;volume=536&#x0026;pages=285&#x2013;291\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B19\" id=\"B19\">\u003C/a>Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. \u003Ci>Bioinformatics\u003C/i> 25, 1754&#x2013;1760. doi: 10.1093/bioinformatics/btp324\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/19451168\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/bioinformatics/btp324\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Fast+and+accurate+short+read+alignment+with+Burrows-Wheeler+transform%2E&#x0026;journal=Bioinformatics&#x0026;author=Li+H.&#x0026;author=Durbin+R.&#x0026;publication_year=2009&#x0026;volume=25&#x0026;pages=1754&#x2013;1760\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B20\" id=\"B20\">\u003C/a>Li, Z., Zhu, P., Huang, H., Pan, Y., Han, P., Cui, H., et al. (2019). Identification of a novel COL4A5 mutation in the proband initially diagnosed as IgAN from a Chinese family with X-linked Alport syndrome. \u003Ci>Sci. China Life Sci.\u003C/i> 62, 1572&#x2013;1579. doi: 10.1007/s11427-018-9545-3\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31209800\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s11427-018-9545-3\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Identification+of+a+novel+COL4A5+mutation+in+the+proband+initially+diagnosed+as+IgAN+from+a+Chinese+family+with+X-linked+Alport+syndrome%2E&#x0026;journal=Sci%2E+China+Life+Sci%2E&#x0026;author=Li+Z.&#x0026;author=Zhu+P.&#x0026;author=Huang+H.&#x0026;author=Pan+Y.&#x0026;author=Han+P.&#x0026;author=Cui+H.&#x0026;publication_year=2019&#x0026;volume=62&#x0026;pages=1572&#x2013;1579\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B21\" id=\"B21\">\u003C/a>Lonergan, G. J., Schwab, C. M., Suarez, E. S., and Carlson, C. L. (2002). Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. \u003Ci>Radiographics\u003C/i> 22, 911&#x2013;934. doi: 10.1148/radiographics.22.4.g02jl15911\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12110723\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1148/radiographics.22.4.g02jl15911\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Neuroblastoma%2C+ganglioneuroblastoma%2C+and+ganglioneuroma%3A+radiologic-pathologic+correlation%2E&#x0026;journal=Radiographics&#x0026;author=Lonergan+G.+J.&#x0026;author=Schwab+C.+M.&#x0026;author=Suarez+E.+S.&#x0026;author=Carlson+C.+L.&#x0026;publication_year=2002&#x0026;volume=22&#x0026;pages=911&#x2013;934\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B22\" id=\"B22\">\u003C/a>Love, M. I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. \u003Ci>Genome Biol.\u003C/i> 15:550.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Moderated+estimation+of+fold+change+and+dispersion+for+RNA-seq+data+with+DESeq2%2E&#x0026;journal=Genome+Biol%2E&#x0026;author=Love+M.+I.&#x0026;author=Huber+W.&#x0026;author=Anders+S.&#x0026;publication_year=2014&#x0026;volume=15&#x0026;issue=550\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B23\" id=\"B23\">\u003C/a>Luksch, R., Castellani, M. R., Collini, P., De Bernardi, B., Conte, M., Gambini, C., et al. (2016). Neuroblastoma (Peripheral neuroblastic tumours). \u003Ci>Crit. Rev. Oncol. Hematol.\u003C/i> 107, 163&#x2013;181.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Neuroblastoma+%28Peripheral+neuroblastic+tumours%29%2E&#x0026;journal=Crit%2E+Rev%2E+Oncol%2E+Hematol%2E&#x0026;author=Luksch+R.&#x0026;author=Castellani+M.+R.&#x0026;author=Collini+P.&#x0026;author=De+Bernardi+B.&#x0026;author=Conte+M.&#x0026;author=Gambini+C.&#x0026;publication_year=2016&#x0026;volume=107&#x0026;pages=163&#x2013;181\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B24\" id=\"B24\">\u003C/a>McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., et al. (2010). The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. \u003Ci>Genome Res.\u003C/i> 20, 1297&#x2013;1303. doi: 10.1101/gr.107524.110\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20644199\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1101/gr.107524.110\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=The+genome+analysis+toolkit%3A+a+MapReduce+framework+for+analyzing+next-generation+DNA+sequencing+data%2E&#x0026;journal=Genome+Res%2E&#x0026;author=McKenna+A.&#x0026;author=Hanna+M.&#x0026;author=Banks+E.&#x0026;author=Sivachenko+A.&#x0026;author=Cibulskis+K.&#x0026;author=Kernytsky+A.&#x0026;publication_year=2010&#x0026;volume=20&#x0026;pages=1297&#x2013;1303\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B25\" id=\"B25\">\u003C/a>Mosse, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., et al. (2008). Identification of ALK as a major familial neuroblastoma predisposition gene. \u003Ci>Nature\u003C/i> 455, 930&#x2013;935. doi: 10.1038/nature07261\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18724359\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nature07261\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Identification+of+ALK+as+a+major+familial+neuroblastoma+predisposition+gene%2E&#x0026;journal=Nature&#x0026;author=Mosse+Y.+P.&#x0026;author=Laudenslager+M.&#x0026;author=Longo+L.&#x0026;author=Cole+K.+A.&#x0026;author=Wood+A.&#x0026;author=Attiyeh+E.+F.&#x0026;publication_year=2008&#x0026;volume=455&#x0026;pages=930&#x2013;935\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B26\" id=\"B26\">\u003C/a>Pertea, M., Pertea, G. M., Antonescu, C. M., Chang, T. C., Mendell, J. T., and Salzberg, S. L. (2015). StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. \u003Ci>Nat. Biotechnol.\u003C/i> 33, 290&#x2013;295. doi: 10.1038/nbt.3122\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25690850\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nbt.3122\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=StringTie+enables+improved+reconstruction+of+a+transcriptome+from+RNA-seq+reads%2E&#x0026;journal=Nat%2E+Biotechnol%2E&#x0026;author=Pertea+M.&#x0026;author=Pertea+G.+M.&#x0026;author=Antonescu+C.+M.&#x0026;author=Chang+T.+C.&#x0026;author=Mendell+J.+T.&#x0026;author=Salzberg+S.+L.&#x0026;publication_year=2015&#x0026;volume=33&#x0026;pages=290&#x2013;295\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B27\" id=\"B27\">\u003C/a>Ramus, S. J., Vierkant, R. A., Johnatty, S. E., Pike, M. C., Van Den Berg, D. J., Wu, A. H., et al. (2008). Consortium analysis of 7 candidate SNPs for ovarian cancer. \u003Ci>Int. J. Cancer.\u003C/i> 123, 380&#x2013;388.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Consortium+analysis+of+7+candidate+SNPs+for+ovarian+cancer%2E&#x0026;journal=Int%2E+J%2E+Cancer%2E&#x0026;author=Ramus+S.+J.&#x0026;author=Vierkant+R.+A.&#x0026;author=Johnatty+S.+E.&#x0026;author=Pike+M.+C.&#x0026;author=Van+Den+Berg+D.+J.&#x0026;author=Wu+A.+H.&#x0026;publication_year=2008&#x0026;volume=123&#x0026;pages=380&#x2013;388\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B28\" id=\"B28\">\u003C/a>Ritenour, L. E., Randall, M. P., Bosse, K. R., and Diskin, S. J. (2018). Genetic susceptibility to neuroblastoma: current knowledge and future directions. \u003Ci>Cell Tissue Res.\u003C/i> 372, 287&#x2013;307. doi: 10.1007/s00441-018-2820-3\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29589100\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00441-018-2820-3\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Genetic+susceptibility+to+neuroblastoma%3A+current+knowledge+and+future+directions%2E&#x0026;journal=Cell+Tissue+Res%2E&#x0026;author=Ritenour+L.+E.&#x0026;author=Randall+M.+P.&#x0026;author=Bosse+K.+R.&#x0026;author=Diskin+S.+J.&#x0026;publication_year=2018&#x0026;volume=372&#x0026;pages=287&#x2013;307\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B29\" id=\"B29\">\u003C/a>Rousset-Jablonski, C., and Gompel, A. (2017). Screening for familial cancer risk: focus on breast cancer. \u003Ci>Maturitas\u003C/i> 105, 69&#x2013;77. doi: 10.1016/j.maturitas.2017.08.004\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28818315\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.maturitas.2017.08.004\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Screening+for+familial+cancer+risk%3A+focus+on+breast+cancer%2E&#x0026;journal=Maturitas&#x0026;author=Rousset-Jablonski+C.&#x0026;author=Gompel+A.&#x0026;publication_year=2017&#x0026;volume=105&#x0026;pages=69&#x2013;77\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B30\" id=\"B30\">\u003C/a>Rudd, M. F., Sellick, G. S., Webb, E. L., Catovsky, D., and Houlston, R. S. (2006). Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. \u003Ci>Blood\u003C/i> 108, 638&#x2013;644. doi: 10.1182/blood-2005-12-5022\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16574953\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1182/blood-2005-12-5022\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Variants+in+the+ATM-BRCA2-CHEK2+axis+predispose+to+chronic+lymphocytic+leukemia%2E&#x0026;journal=Blood&#x0026;author=Rudd+M.+F.&#x0026;author=Sellick+G.+S.&#x0026;author=Webb+E.+L.&#x0026;author=Catovsky+D.&#x0026;author=Houlston+R.+S.&#x0026;publication_year=2006&#x0026;volume=108&#x0026;pages=638&#x2013;644\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B31\" id=\"B31\">\u003C/a>Schwarz, J. M., Cooper, D. N., Schuelke, M., and Seelow, D. (2014). MutationTaster2: mutation prediction for the deep-sequencing age. \u003Ci>Nat. Methods\u003C/i> 11, 361&#x2013;362. doi: 10.1038/nmeth.2890\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24681721\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nmeth.2890\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=MutationTaster2%3A+mutation+prediction+for+the+deep-sequencing+age%2E&#x0026;journal=Nat%2E+Methods&#x0026;author=Schwarz+J.+M.&#x0026;author=Cooper+D.+N.&#x0026;author=Schuelke+M.&#x0026;author=Seelow+D.&#x0026;publication_year=2014&#x0026;volume=11&#x0026;pages=361&#x2013;362\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B32\" id=\"B32\">\u003C/a>Trochet, D., Bourdeaut, F., Janoueix-Lerosey, I., Deville, A., de Pontual, L., Schleiermacher, G., et al. (2004). Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. \u003Ci>Am. J. Hum. Genet.\u003C/i> 74, 761&#x2013;764. doi: 10.1086/383253\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15024693\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1086/383253\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Germline+mutations+of+the+paired-like+homeobox+2B+%28PHOX2B%29+gene+in+neuroblastoma%2E&#x0026;journal=Am%2E+J%2E+Hum%2E+Genet%2E&#x0026;author=Trochet+D.&#x0026;author=Bourdeaut+F.&#x0026;author=Janoueix-Lerosey+I.&#x0026;author=Deville+A.&#x0026;author=de+Pontual+L.&#x0026;author=Schleiermacher+G.&#x0026;publication_year=2004&#x0026;volume=74&#x0026;pages=761&#x2013;764\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B33\" id=\"B33\">\u003C/a>Valencia, O. M., Samuel, S. E., Viscusi, R. K., Riall, T. S., and Neumayer, L. A. (2017). The role of genetic testing in patients with breast cancer: a review. \u003Ci>JAMA Surg.\u003C/i> 152, 589&#x2013;594. doi: 10.1001/jamasurg.2017.0552\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28423155\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1001/jamasurg.2017.0552\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=The+role+of+genetic+testing+in+patients+with+breast+cancer%3A+a+review%2E&#x0026;journal=JAMA+Surg%2E&#x0026;author=Valencia+O.+M.&#x0026;author=Samuel+S.+E.&#x0026;author=Viscusi+R.+K.&#x0026;author=Riall+T.+S.&#x0026;author=Neumayer+L.+A.&#x0026;publication_year=2017&#x0026;volume=152&#x0026;pages=589&#x2013;594\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B34\" id=\"B34\">\u003C/a>Wang, K., Li, M., and Hakonarson, H. (2010). ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. \u003Ci>Nucleic Acids Res.\u003C/i> 38:e164. doi: 10.1093/nar/gkq603\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20601685\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gkq603\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=ANNOVAR%3A+functional+annotation+of+genetic+variants+from+high-throughput+sequencing+data%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Wang+K.&#x0026;author=Li+M.&#x0026;author=Hakonarson+H.&#x0026;publication_year=2010&#x0026;volume=38&#x0026;issue=e164\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B35\" id=\"B35\">\u003C/a>Wenham, R. M., Schildkraut, J. M., McLean, K., Calingaert, B., Bentley, R. C., Marks, J., et al. (2003). Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer. \u003Ci>Clin. Cancer Res.\u003C/i> 9, 4396&#x2013;4403.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Polymorphisms+in+BRCA1+and+BRCA2+and+risk+of+epithelial+ovarian+cancer%2E&#x0026;journal=Clin%2E+Cancer+Res%2E&#x0026;author=Wenham+R.+M.&#x0026;author=Schildkraut+J.+M.&#x0026;author=McLean+K.&#x0026;author=Calingaert+B.&#x0026;author=Bentley+R.+C.&#x0026;author=Marks+J.&#x0026;publication_year=2003&#x0026;volume=9&#x0026;pages=4396&#x2013;4403\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B36\" id=\"B36\">\u003C/a>Yang, Y., Liu, Z., Wang, F., Temviriyanukul, P., Ma, X., Tu, Y., et al. (2015). FANCD2 and REV1 cooperate in the protection of nascent DNA strands in response to replication stress. \u003Ci>Nucleic Acids Res.\u003C/i> 43, 8325&#x2013;8339. doi: 10.1093/nar/gkv737\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26187992\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gkv737\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=FANCD2+and+REV1+cooperate+in+the+protection+of+nascent+DNA+strands+in+response+to+replication+stress%2E&#x0026;journal=Nucleic+Acids+Res%2E&#x0026;author=Yang+Y.&#x0026;author=Liu+Z.&#x0026;author=Wang+F.&#x0026;author=Temviriyanukul+P.&#x0026;author=Ma+X.&#x0026;author=Tu+Y.&#x0026;publication_year=2015&#x0026;volume=43&#x0026;pages=8325&#x2013;8339\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B37\" id=\"B37\">\u003C/a>Yu, G., Wang, L. G., Han, Y., and He, Q. Y. (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. \u003Ci>OMICS\u003C/i> 16, 284&#x2013;287. doi: 10.1089/omi.2011.0118\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22455463\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1089/omi.2011.0118\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=clusterProfiler%3A+an+R+package+for+comparing+biological+themes+among+gene+clusters%2E&#x0026;journal=OMICS&#x0026;author=Yu+G.&#x0026;author=Wang+L.+G.&#x0026;author=Han+Y.&#x0026;author=He+Q.+Y.&#x0026;publication_year=2012&#x0026;volume=16&#x0026;pages=284&#x2013;287\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\r\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B38\" id=\"B38\">\u003C/a>Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., et al. (2015). Germline mutations in predisposition genes in pediatric cancer. \u003Ci>N. Engl. J. Med.\u003C/i> 373, 2336&#x2013;2346.\u003C/p>\r\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?&#x0026;title=Germline+mutations+in+predisposition+genes+in+pediatric+cancer%2E&#x0026;journal=N%2E+Engl%2E+J%2E+Med%2E&#x0026;author=Zhang+J.&#x0026;author=Walsh+M.+F.&#x0026;author=Wu+G.&#x0026;author=Edmonson+M.+N.&#x0026;author=Gruber+T.+A.&#x0026;author=Easton+J.&#x0026;publication_year=2015&#x0026;volume=373&#x0026;pages=2336&#x2013;2346\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\r\n\u003C/div>\r\n\u003C/div>\r\n\u003Cdiv class=\"thinLineM20\">\u003C/div>\r\n\u003Cdiv class=\"AbstractSummary\">\r\n\u003Cp>\u003Cspan>Keywords\u003C/span>: peripheral neuroblastic tumors, neuroblastoma, ganglioneuroma, whole-genome sequencing, RNA-Seq, \u003Ci>BRCA2\u003C/i>, cancer predisposition gene\u003C/p>\r\n\u003Cp>\u003Cspan>Citation:\u003C/span> Yang Y, Chen J, Qin H, Jin Y, Zhang L, Yang S, Wang H, Fu L, Hong E, Yu Y, Lu J, Chang Y, Ni X, Xu M, Shi T and Guo Y (2021) A Novel Germline Compound Heterozygous Mutation of \u003Ci>BRCA2\u003C/i> Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings. \u003Ci>Front. Genet.\u003C/i> 12:652718. doi: 10.3389/fgene.2021.652718\u003C/p>\r\n\u003Cp id=\"timestamps\">\r\n\u003Cspan>Received:\u003C/span> 13 January 2021; \u003Cspan>Accepted:\u003C/span> 31 May 2021;\u003Cbr>\u003Cspan>Published:\u003C/span> 23 July 2021.\u003C/p>\r\n\u003Cdiv>\r\n\u003Cp>Edited by:\u003C/p>\r\n\u003Ca href=\"https://loop.frontiersin.org/people/1353308/overview\">Nadeem Abbas\u003C/a>, Riphah International University, Pakistan\u003C/div>\r\n\u003Cdiv>\r\n\u003Cp>Reviewed by:\u003C/p>\r\n\u003Ca href=\"https://loop.frontiersin.org/people/792280/overview\">Yifan Zhang\u003C/a>, University of Arkansas at Little Rock, United States\u003Cbr>\r\n\u003Ca href=\"https://loop.frontiersin.org/people/661168/overview\">Ting Li\u003C/a>, University of Arkansas at Little Rock, United States\u003C/div>\r\n\u003Cp>\u003Cspan>Copyright\u003C/span> &#x00A9; 2021 Yang, Chen, Qin, Jin, Zhang, Yang, Wang, Fu, Hong, Yu, Lu, Chang, Ni, Xu, Shi and Guo. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY)\u003C/a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\r\n\u003Cp>\u003Cspan>*Correspondence:\u003C/span> Min Xu, \u003Ca id=\"encmail\">amFja3htMTIzNkAxMjYuY29t\u003C/a>; Tieliu Shi, \u003Ca id=\"encmail\">dGllbGl1c2hpQHlhaG9vLmNvbQ==\u003C/a>; \u003Ca id=\"encmail\">dGxzaGlAYmlvLmVjbnUuZWR1LmNu\u003C/a>; Yongli Guo, \u003Ca id=\"encmail\">Z3VveW9uZ2xpQGJjaC5jb20uY24=\u003C/a>; \u003Ca id=\"encmail\">amFja3htMTIzNkAxMjYuY29t\u003C/a>\u003C/p>\r\n\u003Cp>\u003Csup>&#x2020;\u003C/sup>These authors have contributed equally to this work\u003C/p>\r\n\u003Cdiv class=\"clear\">\u003C/div>\r\n\u003C/div>","\u003Cul class=\"flyoutJournal\">\r\n\u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h2\">Introduction\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h3\">Materials and Methods\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h4\">Results\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h5\">Discussion\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h6\">Conclusion\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h7\">Limitations\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h8\">Data Availability Statement\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h9\">Ethics Statement\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#S9\">Author Contributions\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#fun1\">Funding\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#conf1\">Conflict of Interest\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h13\">Publisher&#x2019;s Note\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#ack1\">Acknowledgments\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#S12\">Supplementary Material\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#refer1\">References\u003C/a>\u003C/li>\r\n\u003C/ul>\r\n",[716,721,727,730,736],{"name":717,"fileServerPackageEntryId":19,"fileServerId":718,"fileServerVersionNumber":374,"type":719},"EPUB.epub","652718/epub",{"code":720,"name":720},"EPUB",{"name":722,"fileServerPackageEntryId":723,"fileServerId":724,"fileServerVersionNumber":374,"type":725},"fgene-12-652718.pdf","fgene-12-652718/fgene-12-652718.pdf","652718/pubmed-zip",{"code":726,"name":726},"PDF",{"name":722,"fileServerPackageEntryId":19,"fileServerId":728,"fileServerVersionNumber":374,"type":729},"652718/publishers-proof/pdf",{"code":726,"name":726},{"name":731,"fileServerPackageEntryId":732,"fileServerId":724,"fileServerVersionNumber":374,"type":733},"fgene-12-652718.xml","fgene-12-652718/fgene-12-652718.xml",{"code":734,"name":735},"NLM_XML","XML",{"name":737,"fileServerPackageEntryId":19,"fileServerId":738,"fileServerVersionNumber":374,"type":739},"Provisional PDF.pdf","652718/provisional-pdf",{"code":726,"name":726},"v3",{"title":742,"link":743,"meta":747,"script":909},"Frontiers | A Novel Germline Compound Heterozygous Mutation of BRCA2 Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings",[744],{"rel":745,"href":746},"canonical","https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/full",[748,751,754,756,759,763,766,770,773,776,779,781,783,785,787,789,792,795,797,800,802,804,807,810,813,816,819,823,827,830,833,836,839,842,844,847,849,852,854,857,859,862,865,868,870,873,875,878,880,883,885,888,890,893,896,899,901,904,906],{"hid":749,"property":749,"name":749,"content":750},"description","Objectives To investigate the genetic variants that are responsible for peripheral neuroblastic tumors (PNTs) oncogenesis in one family case. Methods One fam...",{"hid":752,"property":752,"name":753,"content":742},"og:title","title",{"hid":755,"property":755,"name":749,"content":750},"og:description",{"hid":757,"name":757,"content":758},"keywords","peripheral neuroblastic tumors,Neuroblastoma,Ganglioneuroma,Whole- genome sequencing,RNA-Seq,BRCA2,Cancer predisposition gene",{"hid":760,"property":760,"name":761,"content":762},"og:site_name","site_name","Frontiers",{"hid":764,"property":764,"name":367,"content":765},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/652718/fgene-12-652718-HTML/image_m/fgene-12-652718-g001.jpg",{"hid":767,"property":767,"name":768,"content":769},"og:type","type","article",{"hid":771,"property":771,"name":772,"content":746},"og:url","url",{"hid":774,"name":774,"content":775},"twitter:card","summary_large_image",{"hid":777,"name":777,"content":778},"citation_volume","12",{"hid":780,"name":780,"content":116},"citation_journal_title",{"hid":782,"name":782,"content":762},"citation_publisher",{"hid":784,"name":784,"content":697},"citation_journal_abbrev",{"hid":786,"name":786,"content":698},"citation_issn",{"hid":788,"name":788,"content":518},"citation_doi",{"hid":790,"name":790,"content":791},"citation_firstpage","652718",{"hid":793,"name":793,"content":794},"citation_language","English",{"hid":796,"name":796,"content":519},"citation_title",{"hid":798,"name":798,"content":799},"citation_keywords","peripheral neuroblastic tumors; Neuroblastoma; Ganglioneuroma; Whole- genome sequencing; RNA-Seq; BRCA2; Cancer predisposition gene",{"hid":801,"name":801,"content":524},"citation_abstract",{"hid":803,"name":803,"content":533},"citation_article_type",{"hid":805,"name":805,"content":806},"citation_pdf_url","https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/pdf",{"hid":808,"name":808,"content":809},"citation_xml_url","https://public-pages-files-2025.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.652718/xml",{"hid":811,"name":811,"content":812},"citation_fulltext_world_readable","yes",{"hid":814,"name":814,"content":815},"citation_online_date","2021/05/31",{"hid":817,"name":817,"content":818},"citation_publication_date","2021/07/23",{"hid":820,"name":821,"content":822},"citation_author_0","citation_author","Yang, Yeran ",{"hid":824,"name":825,"content":826},"citation_author_institution_0","citation_author_institution","Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, National Center for Childrens Health, Beijing Childrens Hospital, Beijing Pediatric Research Institute, Capital Medical University, China",{"hid":828,"name":821,"content":829},"citation_author_1","Chen, Jiwei ",{"hid":831,"name":825,"content":832},"citation_author_institution_1","Center for Bioinformatics and Computational Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, China",{"hid":834,"name":821,"content":835},"citation_author_2","Qin, Hong ",{"hid":837,"name":825,"content":838},"citation_author_institution_2","Department of Surgical Oncology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China",{"hid":840,"name":821,"content":841},"citation_author_3","Jin, Yaqiong ",{"hid":843,"name":825,"content":826},"citation_author_institution_3",{"hid":845,"name":821,"content":846},"citation_author_4","Zhang, Li ",{"hid":848,"name":825,"content":832},"citation_author_institution_4",{"hid":850,"name":821,"content":851},"citation_author_5","Yang, Shen ",{"hid":853,"name":825,"content":838},"citation_author_institution_5",{"hid":855,"name":821,"content":856},"citation_author_6","Wang, Huanmin ",{"hid":858,"name":825,"content":838},"citation_author_institution_6",{"hid":860,"name":821,"content":861},"citation_author_7","Fu, Libing ",{"hid":863,"name":825,"content":864},"citation_author_institution_7","Department of Pathology, National Center for Childrens Health, Beijing Childrens Hospital, Capital Medical University, China",{"hid":866,"name":821,"content":867},"citation_author_8","Hong, Enyu ",{"hid":869,"name":825,"content":826},"citation_author_institution_8",{"hid":871,"name":821,"content":872},"citation_author_9","Yu, Yongbo ",{"hid":874,"name":825,"content":826},"citation_author_institution_9",{"hid":876,"name":821,"content":877},"citation_author_10","Lu, Jie ",{"hid":879,"name":825,"content":826},"citation_author_institution_10",{"hid":881,"name":821,"content":882},"citation_author_11","Chang, Yan ",{"hid":884,"name":825,"content":826},"citation_author_institution_11",{"hid":886,"name":821,"content":887},"citation_author_12","Ni, Xin ",{"hid":889,"name":825,"content":826},"citation_author_institution_12",{"hid":891,"name":821,"content":892},"citation_author_13","Xu, Min ",{"hid":894,"name":825,"content":895},"citation_author_institution_13","Department of Surgery, Shanghai Childrens Medical Center, School of Medicine, Shanghai Jiao Tong University, China",{"hid":897,"name":821,"content":898},"citation_author_14","Shi, Tieliu ",{"hid":900,"name":825,"content":832},"citation_author_institution_14",{"hid":902,"name":821,"content":903},"citation_author_15","Guo, Yongli ",{"hid":905,"name":825,"content":826},"citation_author_institution_15",{"hid":907,"name":907,"content":908},"dc.identifier","doi:10.3389/fgene.2021.652718",[910,913,915,917,919],{"src":911,"body":13,"type":912,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":914,"body":13,"type":912,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":916,"body":13,"type":912,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":918,"body":13,"type":912,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fgene.2021.652718?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":920,"body":13,"type":912,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":922,"articleHubArticlesList":923,"canJournalHasArticleHub":359,"articleDoiList":924},{},[],[],{"title":19,"image":-1,"breadcrumbs":926,"linksCollection":927,"metricsCollection":929},[],{"total":371,"items":928},[],{"total":371,"items":930},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",publicPagesFilesUrl:"https://public-pages-files-2025.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"RT:IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"RT:IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fgene.2021.652718?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>